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CHAPTER I 
INTRODUCTION 
I.1. Lithium in Medicine 
Lithium was discovered in 1817. Though it has been used medically for more than a 
century, some of the applications are now considered useless or contra-indicated (1,2). After 
the success of lithium in the treatment of mania which was introduced by Cade in 1949 (3), 
lithium has been used more widely in psychiatry. It is a primary drug in the treatment of 
manic and depressive symptoms (1). 
Manic-depression (or bipolar illness) is a psychiatric disorder that is characterized by 
severe mood swings cycling between manic and depressive states. It is a common psychiatric 
disease; it is estimated that at least one in every thousand individuals in the United States, 
Great Britain and Scandinavian countries are undergoing lithium therapy (1). 
Lithium is most commonly administered to patients as lithium carbonate, and given in 
doses of 500-1800 mg per day. The most common side effects of lithium treatment are hand 
tremor, weight gain, increased urination and thirst. Patients with cardiovascular, kidney or 
thyroid disease need to take lithium carefully (4). The uptake of the lithium ion in biological 
tissue is slow; it takes 5-14 days to reach the therapeutic level of 0.3-1.0 mM in sera (1). 
The toxic level of lithium in the plasma is 2 mM. Loss of appetite, aversion to food, nausea 
and vomiting are common early signs of lithium toxicity (4). Although not fully evaluated 
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yet, it is possible to speed up lithium uptake and decrease the therapeutic effective 
extracellular Li+ levels by enriching the drug preparation with the 6Li isotope (5) or by using 
Li+ -selective ionophores ( 6). 
Lithium is also used in the treatment of low white blood cell count resulting from anti-
cancer chemotherapy and conditions caused by the Herpes Simplex virus (1), aggression, 
inflammatory disease and dermatoses (7). The mechanism of lithium action in the treatment 
of manic-depressive illness, however, is still not clear. 
1.2. Proposed Mechanisms of Lithium Action 
Two molecular interrelated mechanisms for the pharmacologic action of lithium have 
been proposed. One mechanism is based on competition between lithium and magnesium ions 
for magnesium binding sites in biomolecules (8,9); the other involves a cell membrane 
abnormality ( 10, 11, 12). 
Lithium interacts with various enzymes and regulates certain metabolic processes (13). 
Its pharmacological effects may result from its regulation of second messenger systems 
through guanosine nucleotide binding proteins (G proteins). Activation of G proteins 
stimulates the enzyme adenylate cyclase, which enhances the synthesis of cyclic adenosine 
monophosphate (cAMP) from ATP to mediate cell function. Moreover, the activated G 
proteins influence phosphoinositide turnover via phospholipase C, triggering the release of 
intracellular stores of calcium which, subsequently, influence cell regulation and ion channel 
coupling. 
At plasma concentrations of 0.6 mM, lithium blocks the activity of two types of G 
proteins, one with stimulatory and the other with inhibitory properties. These two types of 
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G proteins may provide a common site for the antimanic and antidepressive therapeutic effects 
of lithium (14). 
G proteins are known to play an important role in triggering cellular response to outside 
stimulants. They carry information between hormone receptors and specific effectors to 
regulate different intracellular processes. The signal-transducing processes mediated by G 
proteins involve interaction of stimulatory agonists with G proteins, GTP binding to G proteins 
followed by hydrolysis to GDP, and are activated by Mg2+ (14,15). The synthesis of cAMP 
from ATP and the phosphoinositide turnover (Fig. 1) are stimulated by G proteins; the 
adenylate cyclase is also magnesium dependent (16) whereas the phosphoinositide turnover 
system has many potential binding sites for Mg2+. 
The structure of the guanine nucleotide binding domain has been investigated in ras 
protein by two dimensional NMR and X-ray techniques (17-21). Conformational changes 
were observed in active and inactive states. The triggering mechanism for activation of G 
proteins is thought to involve a change in the coordination of the Mg2+ ion at the active site 
(20,21). The three-dimensional structure of inositol monophosphatase was also recently 
studied by X-ray crystallography (22); the binding site for Li+ was identified and was 
proposed to be the target for Li+ therapy. 
Lithium belongs to group IA of the periodic table of elements. Its ionic radius of 0.60 
A is nearly identical to that of the Mg2+ ion (0.65 A). The existence of a diagonal 
relationship between Li+ and Mg2+ in the periodic table results in similar chemical properties, 
allowing for competition between these two metal ions for Mg2+ binding sites in biomolecules 
(8,9). Competition was observed between these two cations for ATP and ADP in aqueous 
solution (23) and for ATP in red blood cells (9). No studies have yet addressed the question 
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Figure 1. G Protein Regulation of Adenylate Cyclase and Phosphoinositide Turnover 
(adapted from reference 15). 
I 
I 
FORSKOLIN 
CHOLERA TOXIN 
OR 
PERTUSSIS TOXIN ® ~ ::: $ ::: 
~~ 
'.J"\f $ $V'VVV" 
....._ -- - -¢"' ~ ::: 
... .... 
... .... 
~ ::: 
... 
INTRACELLULAR 
STORES OF Ca2+ 
VI 
6 
of competition between u+ and Mg2+ ions for substrates of G proteins (24). 
A membrane abnormality has been suggested in the etiology of hypertension (25) and 
manic-depressive (10, 11, 12) illness. The cell membrane dysfunction may involve different 
interactions between G proteins and hormone receptors, leading to abnormal signal-
transduction. 
Human erythrocytes are used in research for studying biological process because of their 
simplicity and availability. Evidence for abnormal phospholipid composition in platelets and 
red blood cell (RBC) membranes of manic-depressive patients was found by thin-layer 
chromatography (26). We and others (10,11,27) have shown that the rates of Na+-u+ 
exchange in RBCs were significantly lower for manic-depressive patients receiving lithium 
carbonate than for normal individuals. In contrast, some investigators did not observe 
difference between patients receiving lithium carbonate and normal individuals (28-33). In 
a systematic investigation of manic-depressive patients withdrawn from lithium carbonate for 
at least three weeks, no differences between patients and normal individuals occurred (34-
36). 
The "Rate constant" is a characteristic of a trans membrane ion transport system and is 
sometimes expressed in the following way: 
(1) 
where v is the flux rate of the metal ion M+, [M+] is the external M+ concentration in influx 
transport experiments or the internal concentration under efflux transport conditions, and k 
is the "rate constant". This equation presupposes a linear relationship between influx (or 
efflux) of M+ and its external (or internal) concentration, but in most cases this assumption 
is not valid. Equation (1) should then be replaced by the Michaelis-Menten equation: 
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(2) 
In this equation, the relationship between v and [M+] is governed by the maximal flux rate 
of M+, V max• and the metal ion M+ dissociation constant K,,,. Equation (2) can be simplified 
to an equation resembling equation (1) when [M+] is substantially lower than K,,,: 
(3) 
Thus, the rate constant k is equal to the ratio V ma/K,,,. The rate constant may vary with 
changes in both maximal rate and metal ion affinity (37); however, the ratio V ma/K,,,, and thus 
the rate constant k, will remain the same if both V max and K,,, increase or decrease by the same 
factor. 
The standard assay for sodium and lithium countertransport activity measures Li+ efflux 
from u+ loaded RBCs into media containing either Na+ at 150 mM or choline-Cl at 112 mM. 
The transport rate is obtained by subtracting the rate in the choline medium from that in the 
Na+ medium. The level of intracellular u+ is adequate to saturate internal ion-binding sites; 
the flux rate is maximal for intracellular u+ levels of 6 to 8 mM. The concentration of Na+ 
in the medium is not sufficient to saturate outer membrane Na+ sites (38). The Na+ affinity 
for external ion-binding sites is 148 mM, which is similar to the concentration of Na+ in the 
transport medium. The Na+ /Li+ exchange rate is not at a maximum at physiologic 
extracellular Na+ levels; the extracellular Na+ level affects the activity observed in the 
standard assay. As discussed above, variations in Na+ affinity (K,,,) or maximal velocity 
(V maJ could change the observed rates. Nevertheless, results obtained under the same 
experimental conditions are still comparable (37). To avoid misinterpretation of transport 
assay data, measurements of binding constants as well as maximum transport rates are 
however required (37). 
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The RBC membrane is made up mostly of proteins and phospholipids, which play an 
important role in determining the ionic permeability of the membrane. A genetically 
controlled RBC membrane protein effects Na+ -Na+ exchange under physiologic conditions 
and, when lithium carbonate is administered, Na+ -Li+ exchange (39). The major 
phospholipids present in the RBC membrane are phosphatidyl choline (PC), phosphatidyl 
ethanolamine (PE), sphingomyelin (Sph), phosphatidyl serine (PS), and phosphatidyl inositol 
(Pl). PC, PE and Sph have neutral head groups at the membrane surface; in contrast, PS and 
PI possess negatively charged head groups that could act as potential binding sites for the Li+ 
ion. They are distributed asymmetrically between the bilayer (40). The outer leaflet contains 
predominately neutral charged phospholipids (40-50% PC, 40-50% Sph and 10-15% PE) while 
the inner leaflet contains predominately negatively charged phospholipids (10-20% PC, 10% 
Sph, 40-50% PE and 20-30% PS). 
One possible consequence of a membrane abnormality is that changes in lipid-protein 
interactions within the RBC membrane may result in alterations in the Li+ transport properties 
of the Na+ -Li+ exchange protein and abnormal Li+ interactions with the RBC membrane. 
The reduced transport rate of bipolar patients receiving lithium carbonate could be related 
to a larger extent of u+ binding to some RBC components. Thus, lithium binding studies in 
RBCs may reveal the mystery of lithium action. 
1.3. G Protein Structure and Function 
G proteins are membrane bound proteins that play an obligatory role in the transduction 
of extracellular, receptor-detected signals across the cell membrane to various intracellular 
effectors (41,42). G proteins consist of three subunits, designated as a, {3 and "f, which are 
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associated with the plasma membrane. G proteins are a{J-y heterotrimers. Large diversity 
occurs in the a subunits, which are thought to directly modulate the activities of various 
effectors; diversity also exists in the {J and 'Y subunits. 
The a subunits behave as hydrophilic molecules while the {J-y subunits are generally 
hydrophobic. The {J-y subunits may anchor the a subunits to the membrane (43). The a 
subunits may be able to reach the channel directly from the aqueous phase and interact with 
membrane, whereas {J-y may be required for insertion into the membrane (44). 
It is possible to isolate G proteins from different sources. For example, oncogene 
human ras proteins have been cloned in E coli, and G proteins were extracted by biochemical 
methods from RBC membranes ( 45). The a subunit subtypes are highly conserved across 
species, with interspecies differences in amino acid sequence of less than 3 % ; this observation 
suggests that each subtype has a specific role in signal transduction (44). The most conserved 
regions are thought to make up the guanine nucleotide binding site on the basis of their 
similarity to the oncogene ras proteins and bacterial EFTu (46-50). The differences in amino 
acid sequence that distinguish one subtype from another are clustered in well defined regions 
of each a subunit (46). The variability occurs between amino acids 85 and 125; it has been 
proposed that this region might be involved in effector interactions (46), but the function of 
this region is still not completely known (44). 
The {J-y subunits are heterogeneous. This heterogeneity may arise partially through 
stable combinations of similar {J subunits with different 'Y subunits. The {J-y subunits can also 
vary in hydrophobicity (44) from very hydrophobic (brain {J-y) to hydrophilic (RBC {J-y). The 
variable hydrophobicity is not due to the amino acid sequence but to interaction between the 
{J and 'Y components. Because native {J and 'Y do not dissociate unless treated with detergent, 
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the f3'Y dimer is believed to form a single functional unit. Either covalent modifications of {3 
or variations in the 'Y subunit create the observed differences in hydrophobicity. 
Determination that stimulation of adenylyl cyclase activity requires both hormones and 
GTP encouraged further research (51). It was demonstrated that {3-adrenergic agonists 
stimulated GTPase activity in RBC and that guanine nucleotides or similar non-hydrolyzable 
analogues [Gpp(NH)p or GTP{3S] modulated the affinity of this receptor for agonists but not 
antagonists. The site of GTP's action may be on a protein distinct from both hormone 
receptor and adenylyl cyclase. 
The structure of the guanine-nucleotide-binding domain was studied in ras p21 proteins 
by X-ray (19-21), two-dimensional NMR (17,18) and EPR (52) methods. ras p21 proteins 
are small guanine-nucleotide-binding proteins (53). They constitute a group of highly 
conserved proteins that function in cell signalling, proliferation and differentiation (54-56). 
Therefore, ras p21 is a useful model for guanine-nucleotide-binding proteins in general. 
Figure 2 is a schematic picture of guanine nucleotide binding domain containing 
guanosine-5'-(/3,'Y- imido)-triphosphate [Gpp(NH)p]. Gpp(NH)p is a non-hydrolyzable 
analogue of GTP. The guanine base is sandwiched between the aromatic side chain of Phe 
28 and the aliphatic part of the side chain of Lys 117. The amino group of Lys 117 is only 
3.5 A away from endocyclic oxygen of the ribose which is close enough to the main chain 
carbonyl group of Gly 13 in the phosphate binding loop. There are many conformational 
differences in the Mg2+ binding domain between the active GTP binding state and the inactive 
GDP binding state. The detailed structures were obtained at a 2.6-A resolution by using X-
ray crystallography (20). In the GTP binding structure, Mg2+ ion is coordinated to the 
nucleotide by the 'Y- and {3- phosphate groups (pro-R oxygen) and to the protein by hydroxyl 
Figure 2. 
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Schematic Drawing of Guanine Nucleotide Binding Domain (from 
reference 19) 
Hydrogen bonds are indicated by open arrows (::::}),bonds between Mg2+ 
and its ligands are shown by solid arrows (-+). 
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groups of Ser 17 and Thr 35. Since Mg2+ is normally hexacoordinated, two molecules of 
water are also coordinated to the metal ion, one of them providing a bridge to the carboxyl 
group of Asp 57 (20). But only the latter has been identified in the p21 GTP structure. Asp 
57 is close in sequences to residue 59 where substitution can influence the transforming 
properties of the protein (57). Thee-amino group of Lys 16 interacts with an oxygen of the 
')'-phosphate, and more weakly, with the {3-phosphate. The /3- and ')'-phosphate groups are 
doubly coordinated with Mgz+ and the NH3 + group of Lys 16. 
Several differences were observed at the active site of GDP state when compared with 
the GTP state, which are directly or indirectly due to the loss of ')'-phosphate group. Lys 16 
still interacts with the backbone carbonyl group of residues 10 and 11, but not with the /3-
phosphate. The distance between the amino group of Lys 16 and the oxygens of the /3-
phosphate group is now too large for interaction. The coordination of Mgz+ is similar to that 
in the GTP state, but only one interaction with the nucleotide at the /3-phosphate group. The 
interaction with Asp 57 is direct, and not through a water molecule as in the triphosphate 
structures. The distance of Mg2+ to Thr 35 increases and is too large for direct interaction. 
Due to a change in the position of Mgz+, large differences in the effector-binding region 
(residues 32-40) between the two states also occurred. Main variabilities were observed 
between residues 32-36. This is the part of the molecule that is thought to interact with GAP 
(GTPase activating protein) (58). Tyr 32 interacts more strongly with the pyrrolidone ring 
of Pro 34 in the GDP structure; it seems likely that a conformational change is associated 
with this interaction. The mechanism of GTP hydrolysis is still controversial (21,59), but Gin 
61 is believed to play a major role in it. 
Based on their function, G proteins are referred to as G;, G., G0 and Gk. G. is involved 
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in the stimulation of adenylyl cyclase while G; is involved in inhibition. Gk is a unique protein 
which opens potassium channels without any other intervening metabolic steps in heart 
(60,61). G0 , in contrast, is one kind of G protein in brain whose function is unknown. 
Molecular cloning techniques have revealed that at least four or more other proteins exist (62). 
It was found that G;-like proteins also activate phospholipase C which hydrolyses 
phosphatidylinositol 4,5-bisphosphate to generate diacylglycerol and inositol 1,4,5-triphosphate 
and modulates the activity of specific ion channels (41,42,63,64). The study of G0 proteins 
in brain tissue led to the understanding that G proteins are a family of homologous proteins 
serving diverse roles in a wide variety of receptor-mediated extracellular signals to various 
intracellular second messenger systems (41,42,63,64). 
G protein cycles between an inactive GDP-bound oligomeric (a{3"() form and an active 
GTP-bound monomeric (a) form (Fig. 3). These two forms of a subunit are described as 
the "off" and "on" positions of a carefully timed molecular switch (42,65). This cycle starts 
from a stimulatory agonist recognized by a receptor. Activation of a receptor by an agonist 
induces a conformational change in the receptor, allowing it to interact with the G protein, 
and forms a short-lived "high affinity ternary complex" consisting of a, {3 and 'Y components. 
The receptor-G protein interaction facilitates the replacement of GDP by GTP on the a 
subunit of G protein. The binding of GTP is a crucial step which causes the G protein to 
dissociate from the receptor and promote dissociation into a-GTP and f3'Y subunits. The a-
GTP complex (G.) activates the effector system (enzyme or ion channel). The continued 
activation is terminated by the action of GTPase which hydrolyses GTP to GDP. The 
formation of a-GDP causes the dissociation of a. from effector and reassociation of a-GDP 
with f3'Y which is thermodynamically stable (51). 
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Figure 3. Scheme for G Protein Signal Transduction (adapted from references 44 and 
51) 
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Inhibitory effects on adenylyl cyclase is based on two distinct mechanisms. First, there 
appears to be a direct inhibitory effect of the ex subunit of G; on the catalytic unit of adenylyl 
cyclase which acts as a parallel system to G.. Second, the /3-y subunits which are released 
by receptor activation of G;, may by mass action attenuate the dissociation of G.. Since the 
concentration of G; is substantially greater than G1 , {3-y subunits may be more potent inhibitors 
of adenylyl cyclase (42,66). When G. is stimulated by a hormone or neurotransmitter, ex; is 
the primary mediator of inhibition of adenylyl cyclase; the {3-y exerts a major role in the 
inhibition of basal- and postreceptor-stimulated adenylyl cyclase activity. 
G proteins serve a critical role in a second messenger system. They amplify or 
attenuate extracellular generated neural signals and then transmit these integrated signals to 
effectors, thus forming the basis for a complex information processing network (67). 
Abnormalities in the function and/or expression of G proteins is implicated in a variety of 
pathophysiologic states: pseudohypoparathyroidism type I, heart failure, certain endocrine 
tumors, McCune-Albright syndrome, diabetes, alcoholism, schizophrenia, mitral valve 
prolapse, chronic cocaine/opiate ingestion, aging, hypo/hyperthyroidism, and 
adrenalectomy/corticosteroid administration (51). G protein dysfunction appears to be a 
primary cause of pathology in Albright's hereditary osteodystrophy, endocrine tumors, and 
McCune-Albright syndrome; in several other conditions, G protein abnormalities are probably 
secondary, but are nonetheless implicated in the pathophysiology of the condition (51). 
1.4. Techniques for Li+ Analysis 
I.4A. Conventional Methods 
Several conventional methods, including atomic absorption (AA), flame emission (FE), 
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UV/VIS, fluorescence, ion-selective electrodes and neutron activation analysis, have been 
applied to monitor u+ levels in biological tissues and aqueous solution (68). Among these 
methods, AA has been used most frequently; it is very selective in that each element emits 
or absorbs radiation at a specific wavelength, and therefore, less prone to interference effects. 
It is also highly sensitive and is able to trace very small amounts of u+ in biological tissues. 
However, all these techniques require physical separation of cells from plasma by 
centrifugation and cell lysing. The intra- or extracellular u+ level is then determined by 
comparison to standard Li+ solutions with a composition similar to the biological tissue being 
analyzed. The invasive nature of these methods may lead to errors due to nonspecific ion 
binding to membranes and cell metabolites and additional ion transport during sample 
processing (68). Moreover, most conventional methods are only useful for obtaining total u+ 
concentrations. No information can be obtained about free and bound states of the Li+ ion. 
Fluorescence and ion-electrodes are the exceptions. The major difficulty is however finding 
a reagent that is highly selective for Li+ ion and yet does not disturb its distribution across 
the cellular membrane. Some success has recently been achieved in this area (69-72). 
1.4.B. NMR Method 
The major advantage of the NMR method is its non-invasiveness which gives clinicians 
and researchers access to physiological information unattainable with conventional 
methodology (73). NMR spectroscopy is however not as sensitive as some of the 
conventional methods, in particular atomic absorption. 
Lithium has two isotopes, 7Li and 6Li. The natural abundance of 7Li (92.6%) is 
considerably higher than that of 6Li (7.4 % ) . Moreover, the receptivity, an NMR parameter 
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which considers the effects of nature abundance, gyromagnetic ratio 'Y and the nuclear spin 
I, is substantially higher for 7Li than for 6Li. These factors make the detection of 7Li routine. 
The lower receptivity of 6Li can be circumvented in biological applications by using lithium 
salts enriched with the 6Li isotope (5,74). 
Both 6Li and 7Li are quadrupolar with nuclear spins equal to 1 and 3/2, respectively. 
The quadrupole moments are very small in both cases, giving rise to narrow NMR lines (75). 
The dipolar relaxation mechanism predominates in the case of 6Li, and is also important in 
the case of7Li (76). 
Because 7Li has a spin at 3/2, in the presence of a magnetic field it has four nuclear 
energy states and undergoes three transitions when pulsed with the correct radio frequency 
(77) (Fig. 4). In general, in a homogeneous system, the energy gaps corresponding to the 
three transitions are the same. Only one "extreme narrowed" peak is observed. Upon 
distortion of the nuclear environment, the nuclear energies may change. As a result, a single 
crystal-like spectrum of three peaks may be observed. Between these two extreme cases, 
there are the homogeneous "biexponential" ("super-Lorentzian") state (78), which only has 
an effect on relaxation, and the inhomogeneous "powder" ("pseudosuper-Lorentzian") state 
(78), in which chemical shifts start to split. 
A tl11 1181 tl11 112 ratio of 7
112 is characteristic for a Lorentzian line shape (79), where tl11 118 
and tl111,2 are the spectral line widths at one-eighth and half intensities of the NMR resonance, 
respectively. If the ratio of tl11 11/tl111,2 is larger than 7112, the resonance is non-Lorentzian (80). 
It can be deconvoluted into a narrow Lorentzian curve responsible for the slow relaxation 
component and a broad Lorentzian curve which is due to the fast component (81). The 
narrow component is associated with the -112 to + 112 transition, whereas the broad 
components relate to the -3/2 to -1/2 and +112 to +3/2 transitions (75,80). 
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Figure 4. Rotating Frame Energy Level Diagrams for an Isolated 1=3/2 System (adapted 
from reference 77) 
a) Homogeneous 'extreme narrowed' spectrum 
b) Single crystal-like spectrum 
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Correlation time, Tc, is a parameter that describes molecular motion. When Tc is much 
shorter than the NMR observation frequency, w, the extreme narrow condition applies (w2T2 
< < 1); the spin-lattice (T,) and spin-spin (Tz) relaxation times are equal and undergo a 
monoexponential decay. The equation is: 
(4) 
where x is the product of the quadrupolar coupling constant, e2qQ/li, and the asymmetry 
factor, 1 +172/3 (75). The eq term is the electric field gradient, eQ is the electric quadrupole 
moment, and Ii is the Planck constant, h, divided by 27r. In a homogeneous magnetic field, 
T2 is inversely proportional to the line width at half-intensity of the signal, ..::iv 112 , and is given 
by the equation: 
(5) 
When Li+ is bound to proteins or intracellular components, Tc is sufficiently large and 
comparable to the NMR observation frequency which results in the T 1 values being much 
larger than the T2 values. For 6Li, though, the relaxation decay is still monoexponential while 
for 7Li it is biexponential (76,82). Fast relaxation decay contributes to slow motion, and slow 
relaxation decay is due to free motion. Two components can be observed in the longitudinal, 
Mz(t), and transverse, MT(t), relaxation mechanisms for 1=3/2; they are expressed by 
equations 6 and 7, respectively (76,81,82). 
Mz(t) = Mz(0)[0.2 exp(-t/T1') + 0.8 exp(-t/T1 ")] (6) 
MT(t) = MT(0)[0.6 exp(-t/T2') + 0.4 exp(-t/T2")] (7) 
where single and double primed symbols denote the relaxation times of the two components. 
When the mole fraction of bound species, pb, is very small compared to that of the free 
species, Pr• in solution: 
1/T1' = 1/T1r + Pi,X
2/10[r/(l +w2702)] (8) 
1/T1" = 1/T1r + pbx2/10[rj(l +4w2r 02)] (9) 
1/T2' = 1/T2r + PJ>X
2Tj20[1 + 1/(1 +w27 0 2)] (10) 
1IT2" = l!Tzr + PJ>X2rj20[1/(l +4w2r0 2) + 1/(1 +w2r 02)] (11) 
Subscripts f and b stand for free and bound states. 
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Li+ ions are in the fast exchange in the 7Li NMR time scale. The observed 7Li 
chemical shift and relaxation values represent the weighted average of free and bound Li+ 
ions. The chemical shifts of 7Li are insensitive to Li+ binding. On the contrary, the 
relaxation values are sensitive to motion (75). Since 7Li is quadrupolar, changes in the 
symmetry of the Li+ environment are expected to alter the relaxation. However, components 
of motion at the resonance frequency contribute to both T, and T2, while slow motions only 
contribute to T2• Therefore, large differences exist between T 1 and T2 for bound u+ ions. 
Thus, 7Li NMR relaxation times constitute a good probe for obtaining information on u+ 
interaction with biological tissues. 
Because the chemical shifts of lithium are generally insensitive to solvation or 
complexation by biomolecules (76,82), a shift reagent (SR) method was developed to 
discriminate intra- and extracellular signals (83,84). Negatively charged lathanide shift 
reagents are soluble in aqueous solution and insoluble in hydrophobic cell membranes, and 
are repelled by the negatively charged head groups of phospholipids at the surface of cell 
membranes. SRs are cell impermeable and remain in the cell suspensions except when SR 
decomposition occurs or when cell membranes are leaky. The most popular shift reagents 
used in biological applications of 7Li NMR are Dy(PPP)t (dysprosium(Ill) triphosphate) and 
Dy(TTHA)3- (dysprosium (III) triethylenetetraminehexaacetate). Because the lanthanide ion 
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in shift reagents is paramagnetic, the NMR resonance of extracellular Li+ is subject to a 
pseudocontact shift, and therefore, is separated from the intracellular signal. Dy(PPP)27-
induces an upfield shift whereas a downfield shift is induced by Dy(TTHA)3-. The opposite 
direction of pseudocontact shifts for Li+ resonance are due to the different locations of the Li+ 
ion relative to the cones around the effective magnetic axes of these shift reagents (74). Since 
the overall negative charge is different for these two SRs, the pseudocontact shift induced by 
Dy(PPP)t is larger than that by Dy(TTHA)3- at same concentration (84). These two SRs can 
also be used in 6Li NMR studies (5). In a 7Li NMR investigation of Na+ /Li+ exchange in 
RBC suspensions, it was found that Dy(PPP)t in the suspension medium could alter the 
rates and membrane potential (85,86,87). Because of the high negative charge of Dy(PPP)27-, 
the amount of extracellular Li+ bound to shift reagent is considerable. 
In addition to the SR method, the Modified Inversion Recovery (MIR) method can also 
be used to discriminate between intra- and extracellular 7Li NMR signals in human RBC 
suspensions (85,86). The MIR pulse sequence (D1-180°-D2-60°-AQ)0 takes advantage of large 
differences between 7Li T1 relaxation values and was applied to human RBC suspensions to 
eliminate the extracellular 7Li resonance and selectively observe the intracellular NMR signal 
(86,88,89). 
CHAPTER II 
STATEMENT OF THE PROBLEMS 
The purpose of this thesis is: 1. to address the competition between lithium and 
magnesium ions for substrates of second messenger systems, and RBC membranes; 2. to 
characterize the major lithium binding sites in human erythrocytes; and 3. to investigate the 
cell membrane abnormality in RBCs of lithium-treated manic-depressive patients. 
Li+ may exert its anti manic and antidepressive effect by competing with Mg2+ for 
biomolecules. Li+ and Mg2+ have similar chemical properties because of the diagonal 
relationship between these two cations; several studies have provided evidence for competition 
between u+ and Mg2+ for biological ligands (8,9,23). u+ can also modulate the activity of 
Mg2+-activated enzymes involved in second messenger systems (14,90,91). 
31P, 13C, 1H NMR spectroscopic methods will be applied to the substrates of second 
messenger systems including cAMP, AMP, IP3, GTP and GDP. The changes in chemical 
shifts induced by the presence of various concentrations of u+ and Mg2+ on the phosphate, 
sugar and base moieties can be monitored to determine which part of the nucleotide structure 
contributes to u+ and Mg2+ binding. Measurements of spin-lattice (T1) relaxation values by 
the inversion recovery pulse sequence will be used to investigate whether competition between 
u+ and Mg2+ ions for the same binding sites exist in aqueous solutions of nucleotides. 
NMR relaxation is characterized by spin-lattice (T1) and spin-spin (Ti) relaxation values. 
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They are similar when molecular motion is fast but different when motion is slow, i.e., strong 
binding and electric field gradient. Previous NMR studies in our laboratory (92,93) showed 
that u+ binds to intracellular components of RBCs; T1 for RBCs loaded with 1.5 mM Li+ 
is 6.0 s, whereas T2 is 0.30 s, indicating that strong Li+ binding exists in RBCs. It is 
however not known which component contributes mostly to u+ binding in human RBCs. 
Measurements of 7Li NMR relaxation values with different RBC components will establish 
which component contributes more toward u+ binding. The larger the difference between 
T 1 and T2 , the stronger the interaction between u+ and that RBC component. 
The viscosity and magnetic properties of intact RBC suspensions are two factors that 
may influence the relaxation times. Hematocrit may affect the viscosity of a RBC suspension. 
The higher the hematocrit, the more viscous the sample. On the other hand, RBCs contain 
hemoglobin which is a mixture of oxy and deoxy. Oxy hemoglobin is diamagnetic while 
deoxy hemoglobin is paramagnetic. Carbon monoxide (CO)- and nitrogen (N2)-treated RBCs 
were used in our experiments to examine the paramagnetic contribution of hemoglobin to 
relaxation times. 
By using 7Li relaxation measurements, I investigated the u+ binding sites in human 
erythrocytes via the investigation of the interaction of Li+ with the RBC components: 
hemoglobin, ATP, DPG, membrane, spectrin-actin network and vesicles. Three forms of 
hemoglobin were used: CO-treated hemoglobin is an irreversible analogue of oxy hemoglobin, 
and is diamagnetic; deoxy hemoglobin and methemoglobin are paramagnetic. Vesicles were 
of two types: inside-out (inner membrane surface outside; IOV) and right-side-out (outer 
membrane surface outside; ROV) vesicles. 7Li NMR relaxation measurements will be used 
to investigate whether Li+ binding to internal RBC components contributes significantly to the 
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relaxation parameters observed in intact RBC suspensions. The measurements in vesicle 
suspensions will be made to examine which side of the RBC membrane contributes mostly to 
Li+ binding. 
To understand the 7Li relaxation behavior in RBC membrane suspensions, partially 
relaxed 7Li NMR spectra will be measured in RBC membrane suspensions containing various 
amounts of Li+, and in Li+ -containing glycerol-water mixtures. 
Abnormal phospholipid composition in platelets and RBC membranes and lower Na+1u+ 
exchange rates were observed in RBCs of manic-depressive patients receiving lithium 
carbonate (10,11,26,27). To address the question of a cell membrane abnormality, AA 
analysis, 7Li NMR relaxation measurements and 31P NMR will be used to investigate the 
Na+ /Li+ exchange rates in RBCs, the interaction of Li+ with RBC membranes and the 
phospholipid components, respectively, from blood of manic-depressive patients taking lithium 
carbonate, and from matched normal individuals. Correlations among Na+/Li+ exchange 
rates, u+ binding to membrane, and phospholipid composition in lithium-treated patients were 
determined. 
CHAPTER III 
EXPERIMENTAL APPROACH 
III.1. Materials 
III.IA. Reagents 
Tris salts of guanosine 5'-triphosphate (GTP) and guanosine 5'-diphosphate (GDP), Tris 
salt of adenosine 3' ,5'-cyclic monophosphate (cAMP), adenosine 5'-triphosphate (ATP), free 
acid form of adenosine 5'-monophosphate (AMP), 2,3-diphosphoglycerate (DPG), Tris-base, 
DEAE-Sephadex A-50, Sephadex G-25, Dowex-50W resin, antifoaming reagent A, 
[Ethylenedinitrilo]tetraacetic acid (EDTA, 99%), Triton X-100, bovine serum albumin (BSA), 
DL-cysteine, DL-glyceraldehyde-3-phosphate, 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB), 
acetylthiocholine chloride, sodium pyrophosphate, sodium arsenate, and /3-NAD were obtained 
from Sigma. Magnesium chloride (MgCl2) hexahydrate, lithium chloride (LiCl), sodium 
chloride (NaCl), potassium chloride (KCl), tetramethylammonium hydroxide, trimethyl 
phosphate (TMP), trimethyl silane (TMS), dysprosium nitrate [Dy(N03) 3], sodium triphosphate 
(Na5PPP), 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid (HEPES), ouabain, potassium 
cyanide (KCN), potassium ferricyanide [K3Fe(CN)6], choline chloride, glucose, sucrose, 
methanol (anhydrous), chloroform (CHC13), deuterated chloroform (CDCl3), and DzO 
(99.5%) were purchased from Aldrich. The lithium salt of inositol 1,4,5 triphosphate (IP3) 
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was from Calbiochem, and the sodium salt was from Research Biochemicals Inc. The protein 
assay dye reagent was purchased from Bio-Rad Chem. Co., and Dextran T70 was from 
Pharmacia. All reagents were used without further purification except for Na5PPP, which was 
recrystallized three times from 40% ethanol and then dried. 
111.lB. Blood Samples 
Fresh packed human red blood cells (RBCs) were obtained from a blood bank (Chicago 
Chapter of Life Source). Whole blood from eight male and two female bipolar patients who 
were receiving lithium carbonate, and from ten normal individuals were obtained from the 
Department of Psychiatry, Loyola University Medical Center, Maywood, IL. Each bipolar 
patient was matched to a normal individual according to gender, race, age, and weight. 
Patients were diagnosed according to the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IIIR, 1990) (94). The patients in this study received between 300 and 2100 
mg of lithium carbonate per day and had been taking lithium for a minimum of 3 weeks or 
for as long as 17 years. Some patients were taking other psychotropic drugs, including 
phenothiazines and benzodiazepines. Because Na+ -Li+ exchange rates are related to the 
occurrence of hypertension (95,96), blood pressure was measured at the time of blood 
drawing, and individuals suffering from hypertension were excluded from the study. 
111.2. Sample Preparation 
lll.2A. Metal Nucleotide Complexes in Aqueous Solution 
The NMR samples for studies of GTP, GDP, cAMP and AMP were buffered at pH 7.4 
with Tris-Cl and tetramethylammonium hydroxide, and the ionic strength was adjusted with 
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Tris-Cl to 0.15 M. The temperature was maintained at 37 °C with the variable-temperature 
unit of the NMR spectrometer. We maintained the pH, ionic strength, and temperature in all 
of our experiments except for 13C and 1H NMR experiments, in which the ionic strength was 
not adjusted, because the Tris resonance overlapped with the nucleotide peaks. The nucleotide 
concentrations used were in the 5 mM to 10 mM range. The concentration of LiCl was 
varied from 5 mM to 150 mM, whereas the MgC1 2 concentration was in the range of 0.5 -
50mM. 
For the u+ and Mg2+ competition study using 7Li relaxation measurements, IP3 in the 
Li+ form was dissolved in 99. 5 % DP at a concentration of 2 mM and the pH of the solution 
was adjusted to 7.4 with tetramethylammonium hydroxide. For 1H and 31P NMR chemical 
shift measurements, and the 7Li relaxation study in u+ -containing solution without Mg2+, IP3 
in the Na+ form was dissolved in 99.5% D20 in the concentration range of 2 to 4 mM and 
the pH of 9 .5 was obtained by titration with N aOH. 
IIl.2B. Preparation of Shift Re32ent 
The K+ form of the shift reagent dysprosium triphosphate, Dy(PPP)t, was prepared 
according to a published procedure (97) and contained 16% residual Na+, as measured by 
atomic absorption (AA) spectrophotometry. K,J>PP was added dropwise to Dy(N03) 3 until 
complete formation of the complex, Dy(PPP)27-, which is indicated by the clearance of the 
solution (75). The final ratio of Dy(N03) 3 and K5PPP was approximately 1:2.5 to 1:3. 
K5PPP was obtained by passage of recrystallized Na5PPP through a Dowex-50W column 
saturated with KCl, then freeze-dried overnight. 
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III.2C. Preparation of Li+-Loaded RBC 
RBCs were washed at least three times in an isotonic choline wash solution (CWS) 
containing 100 mM choline chloride, 10 mM glucose, 85 mM sucrose, and 10 mM HEPES, 
pH 7.4. They were then centrifuged at 7000 g for 5 min at 4 °C in a Savant refrigerated 
centrifuge. Washed RBCs were separated from the plasma and buffy coat by aspiration and 
then kept at 4 °C before use. Li+ -loaded RBCs were prepared by incubating washed packed 
RBCs at 37 °C in an isotonic Li+ -loading medium containing 150 mM LiCl, 10 mM glucose, 
and 10 mM HEPES, pH 7.4. Two u+ loading conditions were applied; one being incubation 
of RBCs in a loading medium at 10% hematocrit for 20-75 minutes, the other being at 16% 
hematocrit for 3 hours (95). Under these loading conditions, the intracellular u+ 
concentrations were approximately 1 mM to 3.5 mM and 8 mM, respectively, as measured 
by AA. After incubation, the Li+ -loaded cells were washed five times using CWS by 
centrifugation at 7000 g for 5 min to remove extracellular Li+. 
III.2D. Preparation of Deoxy and Carbon Monoxy (CO) Li+ -Loaded RBC 
Deoxygenated u+ -loaded RBCs (deoxyRBC) were prepared by gentle passage of moist 
nitrogen gas for 30 min through a suspension of washed u+ -loaded RBCs (intracellular [Li+] 
approximately 3. 0 mM) in the isotonic CWS at 25 % hematocrit. Carbon monoxygenated 
RBCs (CORBC) were prepared in a similar way by bubbling of the u+ -loaded RBC 
suspensions for 30 min with CO gas. DeoxyRBC and CORBC were then washed twice with 
the isotonic choline medium and repacked; their oxygenation states were verified by 
examination of their 31P NMR spectra (98,99). 
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III.2E. Preparation of Carbon Monoxy Hemo2lobin, Deoxy Hemo2lobin and 
Methemo2lobin (100-102) 
Packed RBCs were washed three times by centrifugation at 2000 g for 10 minutes, with 
isotonic buffer containing 150 mM NaCl and 5 mM sodium phosphate, pH 8 (PBS) at 4°C. 
The plasma and buffy coat were removed by aspiration. The washed cells were suspended 
in two volumes of cold distilled water, stirred gently for 30 minutes at 4 °C and restirred for 
another 30 minutes after addition of 1/4 volume of neutral saturated ammonium sulphate 
solution whose pH was adjusted to pH 7 with NaOH. A precipitate was formed and the Hb 
solution was separated by centrifugation for 10 minutes at 18,000 g. Then, it was dialyzed 
against 0.05 M Tris, 0.001 M KCN buffer pH 8.5 (adjusted with HCl); the buffer was 
changed at least three times every 4 hours till sot was not present. Purification of 
hemoglobin was carried out by DEAE Sephadex A-50 chromatography. The column was 
prebalanced to pH 8.5 with Tris-CN buffer. Elution of the various hemoglobin fractions was 
carried out by using a pH gradient produced by a Tris-CN buffer (pH 8.5-7.2) with a flow 
rate of 20 mL per hour. 
To obtain COHb and deoxy Hb, purified Hb was bubbled with carbon monoxide and 
N2 for one hour, respectively. Deoxy Hb is very unstable and easily converted to the oxy 
form in air; all deoxy Hb experiments were therefore performed under N2 • MetHb was 
prepared by oxidation of the purified Hb solution (which was prepared as above except that 
the Tris buffer did not contain CN) with a slight excess of potassium ferricyanide and passage 
down a column of Sephadex G-25. The oxygenation states and concentrations of Hb were 
determined by optical spectroscopy (102,103). The COHb preparation was more than 97% 
pure with less than 3 % metHb; the metHb preparation contained approximately 87% metHb, 
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10% hemichrome, and 3 % oxyHb. The deoxyHb preparation contained less than 3 % metHb. 
The Hb solution, containing 0.1 % antifoaming reagent A, was purged with N2 gas for 1 hr, 
to convert most of the Hb to the deoxy form. The viscosity of the Hb solutions was adjusted 
to 5 cP with glycerol. 
III.2F. Preparation of Unsealed RBC Membrane 004) 
Washed, packed RBCs were lysed in 20 to 40 volumes of hypotonic buffer, 5P8 (5 mM 
sodium phosphate, pH 8). The membrane suspension was washed by centrifugation at 22,000 
g and 4 °C until the membrane was pale white. To avoid the possible interference of Na+ in 
our u+ binding study, a modification of a literature method (104) was used to prepare 
unsealed RBC membranes; 5H8 (5 mM HEPES, pH 8) was used instead of 5P8. 
III.2G. Preparation of IOV and ROV (104.105) 
Unsealed membrane (1 mL) which was extracted in 5P8 buffer was diluted to 40 mL 
with 0.5P8 (0.5 mM sodium phosphate, pH 8). After 0.5 to 30 hours incubation on ice, the 
membranes were pelleted at 28,000 g for 30 minutes and resuspended to 1 mL in 0.5P8 by 
vortex mixing, passed 3-5 times through a No. 27 gauge needle to complete vesiculation. The 
vesicle suspension (2 mL) was overlayed on 3 mL of dextran barrier (4.46 g Dextran T-70 
dissolved in 100 mL 0.5P8, pH 8.3-8.5, d= 1.015 mg/mL). After centrifugation for 40 
minutes at 29,000 g, the top band was collected and washed with 40 volumes of 0.5P8 buffer 
at 29,000 g for 30 minutes. The preparation of ROVs was similar to IOVs except for 
addition of 0.1 mM MgS04 (0.5P8-0.1Mg) after incubation on ice, and the incubation time 
was 1 to 1.5 hour. 
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The two types of vesicle preparations were characterized using sidedness assays of 
acetylcholinesterase and glyceraldehyde-3-phosphate dehydrogenase (G3PD) (104). The RBC 
membrane is asymmetric; the inner surface contains glyceraldehyde 3-phosphate 
dehydrogenase, while the acetylcholinesterase is at the outer surface. DTNB is used in the 
assay of acetylcholinesterase, which follows the appearance of free thiol groups during the 
hydrolysis of acetylthiocholine at 412 nm. The G3PD assay follows the reduction of NAD 
by glyceraldehyde-3-phosphate by the change in its absorbance at 340 nm. 
IIl.2H. Preparation of Spectrin 006) 
RBC membranes were prepared from 5P8 buffer as section III.2F. The membranes 
were then twice suspended in the extraction buffer, 0.3P7.6 (0.3 mM sodium phosphate, pH 
7.6), followed by centrifugation at 20,000 g for 30 minutes, and incubation in 3 volumes of 
extraction buffer at 37 °C for 20 minutes. Finally, the fragmented membranes were pelleted 
by centrifugation at 80,000 g for 1 hour at 2 °C. Spectrin dimers, actins and other water-
soluble proteins were in the supernatant. The products were characterized by SDS 
electrophoresis and the sample was found to contain 85 - 90% spectrin. 
111.21. Extraction and Analysis of Phospholipids 
Extraction of phospholipids in RBC membranes for analysis by 31P NMR spectroscopy 
was conducted as follows (107). RBC membrane (1 - 2 mL) was added slowly to methanol 
(17 mL) and mixed for 10 min. Chloroform (33 mL) was then added, and the sample was 
mixed for an additional 15 min. The resulting extract was filtered through a sintered glass 
funnel and washed with 50 mL of a chloroform/methanol (2: 1) solvent mixture. The filtrate 
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was mixed thoroughly with 0.1 M KCl (in a 1 :0.2 ratio) for removal of all non-lipid 
impurities. The bottom chloroform layer was separated with a separatory funnel fitted with 
a teflon stopper. The purified phospholipids were dried in a rotary evaporator at 30 °C, the 
lipid extract was suspended in solvent mixtures of deuterated chloroform/methanol/deuterated 
EDTA at ratios of 100:40: 10 or 125:8:3. The deuterated EDTA reagent was prepared by 
titration of free acid EDTA with tetramethylammonium hydroxide to pH 6, followed by 
lyophilization and by solubilization in D20 to a final concentration of 0.2 M. The sample was 
then placed in a 10 mm NMR tube and allowed to stand for a few minutes until the aqueous 
phase had separated. The spinning turbine was adjusted along the NMR tube so that only the 
chloroform phase was in the region of signal detection. Integration of the 31P NMR 
resonances was conducted using the software provided by the NMR manufacturer. Each 31P 
NMR resonance in the phospholipid extract of RBC membrane was assigned either by 
comparison to spectra of pure phospholipid standards that were recorded alone or by spiking 
of the extract samples with known amounts of pure phospholipids. The 31P NMR spectra were 
run at 27 °C and locked on the deuterium resonance of deuterated chloroform, which ensured 
magnetic field stabilization. Proton decoupling was applied only during data acquisition with 
W ALTZ-16 decoupling sequence, as previously reported ( 108). 
111.3. Data Analysis 
III.3A. Determination of Metal-Nucleotide Bindin2 Constants from 31P NMR 
Chemical Shifts 
Three different models were applied, which assumed the formation of either 1: 1 or 2: 1 
species alone or a mixture of 1:1 and 2:1 species. For the first model, which assumed 1:1 
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stoichiometry for the Li+ complex of GTP, we used the following equations to calculate the 
binding constant, KuGTP• for the LiGTP complex: 
Oohs = Xo~OTP + Xuo~LiGTP, (12) 
[Li+]eq + KLiOTP[Li+]eq[GTP]eq - [Li+]o = 0, (13) 
where 00 TP and OuoTP• represent the limiting chemical shifts for the free GTP and LiGTP 
species, and oohs represents the observed chemical shift in GTP solutions containing Li+ in the 
0 to 100 mM concentration range; x0 TP and xLioTP are the mole fractions for the same species; 
and the subscripts eq and o denote the equilibrium and starting Li+ concentrations, 
respectively. Equations similar to (12) and (13) were used to calculate the binding constants 
of 1: 1 Li+ complexes of GDP, or of 1: 1 Mg2+ complexes of GTP and GDP. For the second 
model, which assumed 2: 1 stoichiometry for the Li+ complex of GTP, we used equations (14) 
and (15) instead to calculate the binding constant, /Ju£1TP• for Li2GTP species: 
Oohs = Xo~GTP + XL~o~40TP, (14) 
[Li+]eq + 2/jLizCITP[Li+].q[GTP].q - [Li+]o = 0, (15) 
where the symbols have the same meaning as above. We used equations similar to (14) and 
(15) to calculate the binding constants of 2: 1 Li+ complexes of GDP, or of 2: 1 Mg2+ 
complexes of GTP and GDP. The third model, which assumed a mixture of 1: 1 and 2: 1 
species, was based on equations which were combinations of equations (12) and (14) or of 
equations (13) and (15). 
III.3B. 'Li NMR Determination of Li+ Concentration, and Time Constants for Li+ 
Uptake in RBC Suspensions 
Intra- and extracellular Li+ can be separated by 7Li NMR by using a shift reagent. The 
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areas under the intracellular 7Li NMR resonance curve were measured and were converted 
into intracellular Li+ concentrations at a certain time, t, [Li+]0 with the equation 
[Li+]t = [Li+]o x (1 - Ht)/[Ht x (1 + Aou/Ain)], (16) 
where Ain and A0u1 are the peak areas of the intra- and extracellular 7Li + NMR resonances at 
time t, [Li+L is the known starting extracellular u+ concentration, and Ht is the hematocrit 
of the RBC suspension. We obtained relative peak areas by means of the integration routines 
included in the software for the Varian VXR-300 NMR spectrometer. The equation above 
assumes 100% visibility for the intracellular 7Li NMR signal. The visibility factor for 7Li 
NMR resonances in RBC suspensions is still a matter of controversy (86). Because the 
visibility of intra- and extracellular 7Li NMR signals in RBC suspensions is the same (109), 
however, this factor does not affect the conclusions from our u+ uptake studies. 
We calculated the time constants k and [Li+]"" in• the limiting intracellular u+ 
concentrations after a steady state was reached, by fitting the 7Li NMR peak areas at several 
incubation times t to the equation 
(17) 
by means of nonlinear least-squares approximations. 
III.3C. Calculation of Bindine Constants to RBC Membrane and ATP form 'Li 
1 1 Values 
Li+ binding constants (Kb) to the unsealed RBC membranes were determined from 
James-Noggle plots (110) of 7Li T, values observed in RBC membrane suspensions titrated 
with Li+ at increasing concentrations. A two-state model (free Li+ and Li+ bound to the RBC 
membrane) undergoing fast chemical exchange in the NMR time scale was assumed when 
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we calculated the Li+ Kb values from the following equations ( 110-112): 
R1 = l/T1 = R1rXr + R1bxb (18) 
(ARr1 = (RI - R1rr1 = Kb"1{[B](R1b - Rlf)}-l + [Li+l{[B](Rlb - R1r)}"1 (19) 
where R1, R1r, and R1h are the observed, free, and bound relaxation rates of u+ ions in RBC 
membrane samples, Xr and Xb are the mole fractions of free and bound u+, and [Li+] and 
[B] are the total concentrations of Li+ and membrane binding sites. Equation (19) assumes 
one to one stoichiometry for binding at a microscopic level when [B] < < [Li+] (110), which 
is valid under our experimental conditions. The Kb values were obtained from the 
slope/intercept ratios of linear James-Noggle plots of (ARr1 against [Li+]. 
In the Li+ and Mg2+ competition study, the binding constants obtained from equation 
19 are apparent u+ binding constants, K.P' in the presence of Mg2+. u+ and Mgz+ binding 
constants were then obtained from the equation: 
(20) 
where Ku-M• KMg-M are the Li+ and Mg2+ binding constants, and [Mg2 +] is the total Mg2+ 
concentration. KMg-M was obtained from the ratio of slope and intercept using a plot of llK.P 
versus Mg2+ concentration. The reciprocal of the y-intercept was the Li+ binding constant. 
Li+ and Mgz+ binding constants to ATP were generated as described in section III. 3A 
for the GTP/GDP system. Three different models were considered for Li+ binding. Instead 
of 31P chemical shifts (o), we used 7Li spin-lattice relaxation rates (R) as parameters, in which 
R was the reciprocal of T1. The conditional binding constants of u+ (K'u-M) and Mg2+ 
(K' Mg-M) to RBC membranes in presence of ATP were obtained by the following equations: 
K' Mg-M= KMg-M/(1 + [ATP]rKMgATP) (21) 
K'u-M= Ku-M/(l +[ATP]rKLiATP + 2[ATP]r[Li+li/3u.t\TP) (22) 
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where [ATPlr and [Li+lr are the free concentrations of ATP and u+, respectively. 
III.JD. Protein Concentration Determination 
Protein concentration was determined by the "Bradford Assay" method at 595 nm (113). 
The dye reagent (purchased from Bio-Rad Chem. Co.) was diluted five-fold in deionized 
water and filtered through a Whatman No. 1 paper. Standards of protein were prepared from 
bovine serum albumin (BSA). 
III.3E. Statistical Analysis (114) 
The statistical significance of the differences between bipolar patients receiving lithium 
carbonate and normal individuals for the RBC u+ transport and binding parameters, and for 
the phospholipid composition of the RBC membrane, were analyzed by use of a paired 
Student's t-test. Correlation coefficients among Li+ transport and binding parameters and 
phospholipid composition were obtained by using a Pearson product-moment correlation. 
Correlation coefficients 2.. 0.4 were considered significant (p ~ 0.05) for a sample size of 
10. 
111.4. Instrumentation 
III.4A. Nuclear Ma2netic Resonance Spectrometer 
1H, 13C, 31P and 7Li NMR measurements were obtained at 300, 74.6, 121.4 and 116.5 
MHz, respectively, on a Varian VXR-300 NMR spectrometer using a multinuclear probe. 
The spin rate with the 10 mm probe was 16 Hz, and 20 Hz with 5 mm probe. All RBC 
samples were run without spinning to avoid cell settling. Spin-lattice relaxation time (T1) 
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measurements were performed by the inversion recovery method ( 180° -7-90° pulse sequence); 
spin-spin relaxation time (T2) measurements were conducted by using the Carl-Purcell-
Meiboom-Gill sequence [90°-(7-l80°-7)n1· The spacing between pulse sequence was at least 
5T1 for both methods. Table 1 shows the NMR parameters that were used. 
III.4B. Atomic Absorption Spectrophotometer 
A Perkin Elmer 5000 spectrometer equipped with a flame source and a graphite furnace 
was used for AA studies. u+ measurements were performed at a wavelength of 607.8 nm 
and a slit width of 1.4 nm. Acetylene and compressed air were used as fuel and oxidant, 
respectively. The flow rate of fuel to oxidant was 45/50. 
III.4C. UV /Vis Spectrophotometer 
All studies were conducted on an IBM UV/Vis 9420 spectrometer. The protein 
concentration was determined at 595 nm by using the "Bradford Assay" (113); oxygenation 
stage and concentration of hemoglobin were determined in the range of 400 to 700 nm 
(102,103). 
III.4D. Centrifuee 
A Savant refrigerated centrifuge, model HSC 10000, was used for general blood 
processing. Membranes were prepared by using a Beckman 12-21 refrigerated centrifuge 
equipped with JA-14 and JA-20 fixed angle rotors. A Sorvall refrigerated ultra centrifuge, 
model OTO 65B, equipped with a T865 rotor, was used for the spectrin preparation. 
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Table 1. NMR Parameters of Nuclei Investigated at 7.0 T. 
Frequency /MHz 300.0 74.6 121.4 116.5 
SW /KHz 10 16 10 4.5 
AT Is 3.8 1.3 1.5 1.2 
PW 90 /µs 20 17.5 12 Tr, 3'1, 12" 
Flip angle /degree 60 45 45 45 
Delay /s 0 1 - 3 0-4 30 
a90o pulse width in low ionic strength solutions (0 - 20 mM) in the 10 mm probe. b90° pulse 
width in high ionic strength solutions (150 mM) in the 10 mm probe. c90° pulse width in low 
ionic strength solutions (0 - 20 mM) in the 5 mm probe. 
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III.4E. Osmometer 
The osmolarity of all RBC suspension media was checked with a Wescor vapor pressure 
osmometer model 5500 and adjusted to 300 + 10 mosM with sucrose and distilled water. 
III.4F. Hemofuee 
Hematocrits (cell volume percentage) were measured using an IEC model MB IMl 16 
hemofuge. 
III.4G. Lyophilizer 
Recrystalizations of K5PPP and EDTA-N(CH3) 40H salts were performed on a FDX 
Flexi-Dry 1-54 freezer drier after freezing. 
III.4H. Viscometer 
The viscosities of Hb, DPG and spectrin were measured with a Brookfied Cone Plate 
Viscometer, equipped with a 8° CP-40 cone, at 12 rpm; they were adjusted with glycerol to 
5 cP to correspond to the viscosity inside RBCs (115). 
CHAPTER IV 
RESULTS 
IV.1. Competition Between Li+ and Mg2+ for Substrates of Second Messenger Systems, 
and RBC Membrane 
IV.lA. Competition Between Li+ and Me2+ for GDP and GTP in Aqueous Solution 
Figure 5 depicts the structure of GTP. We investigated whether metal ion binding to 
GTP and GDP takes place via the base, sugar, or phosphate moiety. We probed metal ion 
binding to the base and sugar domains by using 1H and 13C NMR, whereas we studied metal 
ion binding to the phosphate groups by 31P NMR. We also studied competition between Li+ 
and Mg2+ ions for binding sites in guanine nucleotides by using 7Li NMR relaxation 
measurements and 31P NMR chemical shifts. 
IV.IA.a. 7Li+ NMR T1 Measurements 
Figure 6 shows the T1 values for 7Li in solutions of GTP or GDP containing both Li+ 
and Mg2+ ions. Li+ ions are in fast exchange on the 7Li NMR time scale; the observed 7Li 
chemical shift and T1 values therefore represent the weighted average of free and bound Li+ 
ions. Because the 7Li+ nucleus has a narrow chemical shift range (76), the 7Li NMR chemical 
shifts were not sensitive to Li+ binding to nucleotides. In contrast, 7Li T1 relaxation times are 
sensitive to.motion. Free nuclei have long T1 values, whereas those that are tightly bound, 
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Figure 5. Structure of GTP. The primed symbols indicate the numbering of the sugar 
atoms, and the unprimed symbols the numbering of the base atoms. The positions of 
phosphate groups are denoted by a, {3, and 'Y· In GDP, the 'Y phosphate is not present. 
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Figure 6. 7Li T1 Values for Li-GTP (open symbols) and Li-GDP (closed symbols) in the 
Presence of Increasing Concentrations of Mg2+. The u+ concentration was 5.0 mM in all 
samples. The nucleotide concentrations were 3.0 mM (circles), 5.0 mM (squares), and 7.0 
mM (triangles). Each value is an average of two readings made on separately prepared 
samples. 
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if visible by 7Li NMR, have relatively short T 1 values (116). The T 1 values for 7Li decreased 
in the presence of increasing concentrations of GTP and GDP (Figure 6). In the presence 
of increasing concentrations of Mg2+, the 7Li T 1 values increased. 
IV. lA.b. 13C and 1H NMR Chemical Shift Measurements 
Figures 7 and 8 are 13C and 1H NMR spectra of GTP, respectively. Table 2 shows 1H 
and 13C NMR chemical shifts of the base and sugar moieties of GTP and GDP in the absence 
and presence of saturating amounts of u+ and Mg2+. The H8 proton resonance of the base 
and the HI' proton resonance of the sugar of GTP and GDP showed almost no changes in 
chemical shifts upon addition of either excess LiCl or excess MgCl2• No other proton 
resonances for GTP or GDP were observed because the large water envelope and line 
broadening was induced by rapid exchange between NH or OH protons in the base and sugar 
domains and the solvent protons. The 13C chemical shift changes that occurred upon addition 
of saturating amounts of LiCl or MgCl2 were also very small. 
IV. lA.c. Measurements or31P NMR Chemical Shifts and Metal Ion Binding Constants 
Figure 9 shows the 31P NMR spectra of GTP. The changes in the 31P NMR chemical 
shifts indicate that metal ions bind to the phosphate moiety of nucleotides. The chemical shift 
of the )'-phosphate resonance, to a greater extent that of the /j-phosphate, moved downfield 
upon addition of metal ions. Very small 31P chemical shift changes were observed for the a-
phosphate resonance. The chemical shift separation between the a- and /j-phosphate 
resonances of GTP (o"'13) indicates the state of metal ion complexation of GTP. The value of 
o"'13 varies from its maximum value of 10.93 ppm in free GTP (Fig. 9A) to its minimum value 
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Figure 7. 13C NMR Spectrum of GTP. The GTP concentration was 10 mM. All experiments 
were conducted at pH 7.4 and 37 °C. Chemical shifts were referenced relative to an external 
standard of tetramethylsilane (TMS). Refer to figure 5 for structure assignments. 
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Figure 8. 'H NMR Spectrum of GTP. (A) with water suppression; (B) without water 
suppression, and at 37 °C. The GTP concentration was 10 mM. All samples were prepared 
in 95% op, adjusted to pH 7.4. The presaturation technique was employed to suppress the 
water resonance in (A). Chemical shifts were referenced relative to an internal reference of 
t-butanol. Refer to figure 5 for structure assignments. 
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Table 2. 1H and 13C NMR Chemical Shifts (in ppm) of GTP and GDP a,b 
GTP GDP 
Resonance No metals w I Li+ w/ Mg2+ No Metals w/ Li+ w/ Mg2+ 
Hs 8.12 8.11 8.12 8.11 8.15 8.12 
H •. 5.90 5.90 5.90 5.90 5.93 5.92 
C2 157.7 157.7 157.7 157.7 157.7 157.6 
C4 155.4 155.3 155.4 155.2 155.3 155.4 
Cs 120.0 119.8 119.9 120.0 120.1 119.8 
c6 162.6 162.6 162.7 162.8 162.8 162.6 
Cs 141.5 141.4 141.4 141.5 141.4 141.3 
c •. 90.5 90.6 90.5 90.7 90.6 90.3 
C2. 74.2 74.1 74.0 73.9 74.1 74.2 
C3. 77.3 77.7 77.4 77.4 77.4 77.5 
C4. 87.8 87.1 87.4 87.5 87.5 87.4 
Cs- 59.1 58.9 59.2 59.0 58.5 58.9 
aPrimed resonances are due to sugar protons or carbons, whereas unprimed resonances are 
due to atoms in the guanine base. ~he concentration of nucleotide was 10 mM, and the 
concentrations of LiCl and MgC12 were 150 mM and 50 mM, respectively. Each value is an 
average of two readings on separately prepared samples. The errors are less than 0.02 ppm 
for 1H NMR and less than 0.5 ppm for 13C NMR. 
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Figure 9. 31P NMR Spectra of GTP. (A) 5.0 mM Tris-GTP, (B) 5.0 mM Tris-GTP with 
100 mM LiCl, (C) 5.0 mM Tris-GTP with 100 mM LiCI and 1.5 mM MgC12, and (D) 5.0 
mM GTP with 5.0 mM MgCl2• Ionic strength, pH, and temperature were maintained at 0.15 
M, 7.4, and 37 °C, respectively. No line broadening was used, and trimethyl phosphate 
served as the external reference. 
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of 8.59 ppm in Mg2+ -saturated GTP (Fig. 9D). The values of oa{j for Li+ -saturated GTP 
(9.84 ppm; Fig. 9B) or GTP in the presence of a mixture of u+ and Mg2+ ions (9.39 ppm; 
Fig. 9C) are intermediate between those observed for free GTP and for Mg2+ -saturated GTP 
alone. 
We fitted the 31P NMR chemical shifts for the phosphate resonances of GTP and GDP 
(Tables 3 and 4), as measured in the absence or presence of LiCl or MgCl2 alone and for 
LiCl/MgC12 mixtures, to three different models (see III.3A.) to generate binding constants 
(Tables 5 and 6). Because of the lower charge and correspondingly lower affinity of Li+ 
relative to Mg2+ for both GTP and GDP, we used larger concentrations of u+ (0 to 100 mM) 
than of Mgz+ (0 to 15 mM) in the u+ and Mg2+ titration of both nucleotides. In ion 
competition experiments, the Mgz+ concentration was kept constant at 1.5 mM for GTP and 
at 3.0 mM for GDP; the u+ concentration ranged from 0 to 100 mM. Under these 
conditions, we observed appreciable changes in 31P chemical shifts in individual nucleotide 
titration with u+ or Mg2+ alone and in ion competition experiments. 
IV.lB. Interactions of Li+ and Mif+ with cAMP. AMP and IP3 
Figure 10 shows the structures of cAMP, AMP and IP3 • A similar experimental 
approach to that used for GTP and GDP was applied to these three substrates. 
7Li NMR relaxation measurements (Table 7) showed that the T 1 values remained 
constant with increasing concentrations of either cAMP or AMP, indicating no interaction 
between u+ and AMP or cAMP under these conditions; the T 1 values observed were similar 
to those of LiCl in the absence of nucleotides. Very small changes were observed in the 13C 
chemical shifts of AMP and cAMP upon addition of either saturating concentrations of u+ 
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Table 3. 31P NMR Chemical Shifts of GTP with Various Li+ and Mg2+ Concentrations 
(n=2)° 
[Mg2+]/mM [Li+]/mM hjppm h,/ppm h/ppm 
0 0 -14.19 ± 0.03 -25.12 ± 0.06 -9.80 ± 0.09 
0 15 -14.10 ± 0.04 -24.80 ± 0.04 -9.60 ± 0.04 
0 30 -14.06 ± 0.05 -24.49 ± 0.07 -9.47 ± 0.04 
0 45 -13.98 ± 0.01 -24.31 ± 0.05 -9.26 ± 0.05 
0 60 -13.92 ± 0.01 -24.07 ± 0.05 -9.05 ± 0.02 
0 75 -13.86 ± 0.03 -23.89 ± 0.05 -8.87 ± 0.02 
0 100 -13.80 ± 0.03 -23.64 ± 0.07 -8.68 ± 0.06 
1.0 0 -14.10 ± 0.01 -24.60 ± 0.01 -9.66 ± 0.01 
1.5 0 -14.04 ± 0.02 -24.47 ± 0.06 -9.49 ± 0.08 
2.0 0 -13.98 ± 0.01 -24.04 ± 0.01 -9.36 ± 0.02 
2.5 0 -13.90 ± 0.02 -23.57 ± 0.08 -9.17 ± 0.01 
3.0 0 -13.80 ± 0.01 -23.24 ± 0.02 -8.93 ± 0.01 
3.5 0 -13.79 ± 0.01 -22.98 ± 0.06 -8.88 ± 0.02 
4.0 0 -13.70 ± 0.00 -22.49 ± 0.01 -8.68 ± 0.01 
5.0 0 -13.64 ± 0.01 -22.23 ± 0.03 -8.50 ± 0.02 
15 0 -13.79 ± 0.01 -22.15 ± 0.00 -8.70 ± 0.03 
1.5 15 -13.94 ± 0.01 -23.96 ± 0.02 -9.23 ± 0.02 
1.5 30 -13.89 ± 0.01 -23.80 ± 0.05 -9.10 ± 0.00 
1.5 45 -13.85 ± 0.02 -23.57 ± 0.07 -8.99 ± 0.05 
1.5 60 -13.81 ± 0.01 -23.39 ± 0.07 -8.86 ± 0.01 
1.5 75 -13.77 ± 0.01 -23.27 ± 0.02 -8.73 ± 0.01 
1.5 100 -13.72 ± 0.02 -23.11 ± 0.02 -8.59 ± 0.01 
aGTP concentration, ionic strength, pH, and temperature were maintained at 5 mM, 0.15 M, 
7.4, and 37 °C, respectively; trimethyl phosphate served as the external reference. 
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Table 4. 31P NMR Chemical Shifts of GDP with Various Li+ and Mg2+ Concentrations 
(n=2)° 
[Mg2+]/mM [Li+]/mM ojppm o/ppm 
0 0 -13.77 ± 0.04 -9.78 ± 0.05 
0 15 -13.53 ± 0.02 -9.57 ± 0.03 
0 30 -13.47 ± 0.05 -9.54 ± 0.02 
0 45 -13.26 ± 0.01 -9.37 ± 0.07 
0 60 -13.22 ± 0.04 -9.31 ± 0.05 
0 75 -13.10 ± 0.02 -9.25 ± 0.06 
0 100 -12.93 ± 0.04 -9.00 ± 0.01 
1.0 0 -13.62 ± 0.00 -9.69 ± 0.00 
1.5 0 -13.57 ± 0.01 -9.63 ± 0.01 
2.0 0 -13.53 ± 0.01 -9.59 ± 0.01 
2.5 0 -13.47 ± 0.02 -9.50 ± 0.01 
3.0 0 -13.42 ± 0.02 -9.41 ± 0.04 
3.5 0 -13.37 ± 0.02 -9.40 ± 0.02 
4.0 0 -13.33 ± 0.01 -9.34 ± 0.00 
5.0 0 -13.24 ± 0.02 -9.26 ± 0.02 
15 0 -13.00 ± 0.01 -9.04 ± 0.01 
30 0 -12.96 ± 0.02 -9.12 ± 0.02 
3.0 15 -13.34 ± 0.00 -9.32 ± 0.05 
3.0 30 -13.27 ± 0.01 -9.27 ± 0.01 
3.0 45 -13.19 ± 0.01 -9.16 ± 0.01 
3.0 60 -13.11 ± 0.01 -9.06 ± 0.03 
3.0 75 -13.04 ± 0.01 -9.01 ± 0.03 
3.0 100 -12.92 ± 0.01 -8.91 ± 0.00 
aGDP concentration was 5 mM; other conditions are the same as for Table 3. 
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Table 5. 31P NMR Chemical Shift Data Analysis in the Presence of LiCl or MgCl2 Alone 
GTP GDP 
(3 (3 
A) LiCl Alonea 
1: 1 species only 
K (M.1) 4 6 2 6 3 
olhoorb -12.76 -21.18 -0.50 -11.64 -6.44 
E2 c 0.0006 0.0013 0.00548 0.0078 0.01188 
2: 1 species only 
K (M-2) 535 734 372 75 48 
olhoorb -13.73 -23.48 -8.34 -12.87 -8.90 
E2 c 0.0024 0.0326 0.0104 0.0255 0.0311 
1: 1 and 2: 1 species 
1: 1 K (M- 1) 253 174 166 394 414 
2:1 K (M.2) 1981 6217 1990 408 357 
1: 1 othoorb -14.01 -25.14 -9.58 -13.58 -9.65 
2: 1 othoorb -13.32 -22.50 -7.69 -6.11 -1.39 
E2 c 0.0001 0.0001 0.0010 0.00538 0.00848 
o.x/ -13.80 -23.64 -8.68 -12.93 -9.00 
B) MgCl2 Alone' 
1: 1 species 
K (M-1) 20,000 20,000 20,000 10,000 10,000 
othoerb -13.58 -22.02 -8.45 -13.06 -9.13 
o.x{ -13.64 -22.23 -8.50 -13.24 -9.26 
E2 c 0.0035 0.1100 0.0378 0.0007 0.0047 
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Footnote for Table 5: 
aBinding constants for Li-GTP and Li-GDP calculated from 31P NMR chemical shift data. The 
nucleotide concentration was 5 mM, and the LiCl concentrations ranged from 0 to 100 mM. 
botheor values were calculated from equations similar to (12) through (15). '"E2 values are the 
sums of squared deviations. do•xp were measured from 31P NMR spectra for [Li+] = 100 mM. 
'Binding constants for Mg-GTP and Mg-GDP were calculated from 31P NMR chemical shift 
data. The nucleotide concentration was 5 mM, and the MgCl2 concentrations ranged from 0 
to 15 mM. 1o•xp values were measured from 31P NMR spectra for [Mg2+] = 5.0 mM. gNo 
convergence was found. 
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Table 6. 31 P NMR Chemical Shift Data Analysis in the Presence of Both LiCl and MgCl2° 
GTP GDP 
/3 /3 
A) 1: 1 species only 
K (M-1) 68 49 67 2 4 
ollieorb -13.76 -23.62 -8.62 -6.58 -5.49 
E2 c 0.0810 0.1496 0.1120 0.0002· 0.0012· 
B) 2: 1 species only 
K (M-2) 1250 799 1521 12940 645 
ollieo: -13.76 -23.62 -8.62 -13.37 -8.48 
E2 c 0.1020 0.8320 0.0820 0.4870 0.0045 
C) 1: 1 and 2: 1 species 
1:1 K (M-1) 15 1.4xl0-6 1.8xl0-7 542 2683 
2:1 K (M-2) 712 1666 805 3327 21640 
1: 1 ollieorb -14.02 -24.53 -9.40 -13.56 -9.50 
2: 1 ollieorb -13.71 -23.65 -8.65 -11.61 -8.06 
E2 c 0.0013 0.0530 0.0177 0.0000 0.0008 
oex/ -13.80 -23.64 -8.68 -12.92 -8.91 
°For the competition experiments, the nucleotide was 5.0 mM, and the Li+ concentration 
ranged from 0 to 100 mM. The Mg2+ concentrations in the GTP and GDP experiments were 
1.5 mM and 3.0 mM, respectively. bollieor values were calculated from equations similar to 
(12) through (15). KMgGTP and KMgooP were fixed at 2xl04 M-' and lxl04 M-1, respectively. ~2 
values are the corresponding sums of squared deviations. doexp were measured from 31P NMR 
spectra for [Li+] = 100 mM, and [Mg2+] = 1.5 mM for GTP, and [Mg2+] = 3.0 mM for 
GDP. 'No convergence was found. 
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Figure 10. Structures of cAMP, AMP and IP3 • In AMP and cAMP, the primed symbols 
indicate the numbering of the sugar atoms, and the unprimed symbols the numbering of the 
base atoms. 
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Table 7. 7Li T1 Values of cAMP and AMP (n=2t 
[cAMP]/mM [AMP]/mM [Li+]/mM T/s 
0 0 5 24.5 ± 1.0 
5 0 5 24.3 ± 0.9 
7 0 5 26.7 ± 1.8 
10 0 5 25.8 ± 1.0 
10 0 2 25.5 ± 0.2 
0 5 5 24.3 ± 0.3 
0 10 5 25.1 ± 0.9 
0 10 2 25.1 ± 1.0 
alonic strength, pH, and temperature were maintained at 0.15 M, 7.4, and 37 °C, respectively. 
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or Mg2+ (Table 8). No significant changes in the 31P chemical shifts were observed, except 
in 5 mM AMP solution containing 50 mM Mg2+, where the phosphate resonance experienced 
a 0.4 ppm upfield shift (Table 9). Two resonances separated by 21 Hz were observed in the 
31P spectrum of cAMP but not in that of AMP. This is due to a particular spin-spin coupling 
pattern mainly induced by the nonequivalence of the two protons at the 5' position of the 
sugar moiety whose couplings to phosphorus are very different (117). 
Table 10 and Figure 11 depict the 7Li T 1 values of a solution containing 2 mM IP3 and 
2 mM to 1.4 M Li\ and a solution of 6 mM u+ and 2 mM IP3 and various concentrations 
of Mg2+, respectively. As the amount of u+ increased, T 1 values increased due to the 
increment in the fraction of free u+ in solution; however, for a fixed u+ concentration, as 
the amount of Mg2+ in solution increased, the T 1 values increased which indicated that Mg
2
+ 
replaced Li+ bound to IP3 • 
Figure 12 shows 31P and 1H NMR spectra of IP3 • The inorganic phosphate (PJ 
resonance in the 31P NMR spectrum is due to the hydrolysis of IP3, which was 4 % of the total 
amount. Table 11 shows 1H chemical shifts of the inositol moiety in the absence and presence 
of u+ and Mg2+. The resonances correspond to -CH- groups; -OH groups can not be 
resolved because they exchanged rapidly with water. Since phosphate groups were in an 
intermediate state of exchange at neutral pH, a pH value of 9.5 was used in both 31P NMR 
and 1H NMR spectra of IP3 (118). Almost no changes in the 1H chemical shifts of IP3 were 
observed upon addition of either excess Li+ or Mg2+. In contrast, upfield shifts in the 31P 
NMR spectra of IP3 were observed for the P4 and P5 resonances upon addition of u+, whereas 
the P1 resonance also experienced an upfield shift with excess Mg2+ (Table 12). 
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Table 8. 13C NMR Chemical Shifts (in ppm) of cAMP and AMP a,b 
cAMP AMP 
Resonance No metals w I Li+ w/ Mg2+ No Metals w/ u+ w/ Mg2+ 
C2 156.9 156.7 156.6 155.2 155.0 155.0 
C4 152.3 152.1 152.0 152.9 152.6 152.6 
Cs 122.7 122.6 122.5 122.5 122.2 122.2 
c6 159.5 159.3 159.2 159.5 159.2 159.2 
Cs 143.8 143.7 143.5 142.7 142.4 142.5 
c •. 95.6 95.4 95.3 91.5 91.7 91.9 
C2. 71.2 71.0 70.9 74.6 74.3 74.5 
C3. 75.9 75.8 75.7 78.4 78.1 78.7 
c4. 81.2 81.0 80.8 89.6 89.3 89.2 
Cs. 63.9 65.0 65.0 65.4 65.3 65.5 
0 Primed resonances are due to sugar protons or carbons, whereas unprimed resonances are 
due to atoms in the guanine base. 1The nucleotide concentration was 10 mM and the 
concentrations of LiCl and MgCl2 were 150 mM and 50 mM, respectively. Each value is an 
average of two readings on separately prepared samples. The errors are less than 0.5 ppm. 
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Table 9. 31P NMR Chemical Shifts of cAMP and AMP (n=2t 
c5/ppm 
[Li+]/mM [Mg2+]/mM cAMP (5 mM)b AMP (5 mM) 
0 0 2.61 7.93 
100 0 2.63 7.90 
500c 0 2.64 8.08 
0 5 2.64 7.79 
0 50 2.60 7.54 
alonic strength, pH, and temperature were maintained at 0.15 M, 7.4, and 37 °C, respectively. 
No line broadening or proton decoupling was used, and 85 % H3P04 served as the external 
reference. The errors are less than 0.1 ppm. bMidpoint between doublet resonances. 
cSample ionic strength was larger than 0.15 M. 
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Table 10. 7Li T1 Values of Li+ -Containing IP3 Solutions 0 
[Li+]/mM T/s 
2.0 2.06 ± 0.09 
4.0 2.46 ± 0.07 
10 2.91 ± 0.01 
20 3.49 ± 0.09 
50 4.81 ± 0.15 
80 5.82 ± 0.12 
120 7.19 ± 0.44 
160 7.37 ± 0.12 
220 8.23 ± 0.09 
300 8.82 ± 0.21 
400 9.83 ± 0.27 
600 10.54 ± 0.20 
800 11.61 ± 0.19 
1200 12.61 ± 0.27 
1400 13.23 ± 0.26 
freeb 21.59 ± 0.88 
0 IP3 in Na+ form was used in this experiment; pH was adjusted to 9.5 by NaOH and ionic 
strength was not controlled. NMR measurements were conducted in a 5 mm probe and at 
room temperature (20 °C). bValue was obtained in 10 mM LiCl solution without IP3• 
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Figure 11. 7Li T1 Values for Li+-IP3 Solution Containing Various Mg2+ Concentrations. 
The u+ concentration was 6.0 mM, IP3 was 2 mM and the solution pH was 7.4. NMR 
measurements were performed at room temperature and in 5 mm probe. Each value is an 
average of two readings made on the same sample. 
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Figure 12. 1H (A) and 31P (B) NMR Spectra of IP3• The concentration of IP3 (in the sodium 
salt form) was 4 mM. Samples were prepared in 99.5% 0 20, the pH adjusted to 9.5 with 
NaOH, and the spectra obtained at 20 °C. The presaturation technique was employed to 
suppress the water resonance in the 1H NMR spectrum. 31P chemical shifts were referenced 
to external 85% H3P04 ; 1H chemical shifts were quoted relative to TMS but referenced to 
2HHO at 4.8 ppm at pH 9.5; 0.5 Hz line broadening was used in both spectra. Chemical 
shift assignments were according to reference 118. 
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Table 11. 1H Chemical Shifts of IP3 With or Without Saturating Amounts of Li+ and Mg2+ .a 
Hb 
I H2 H3 H4 Hb 5 Hb 6 
IP3 alone 3.88 4.27 3.69 4.15 3.88 3.88 
IP3 with 50 mM Li+ 3.89 4.27 3.69 4.14 3.89 3.89 
IP3 with 100 mM Li+ 3.90 4.27 3.70 4.15 3.90 3.90 
IP3 with 20 mM Mg
2+ 3.92 4.26 3.70 4.16 3.92 3.92 
aconditions were the same as for Figure 12. bH 1, H5 and H6 resonances overlapped; the data for these three resonances are 
approximate chemical shift values. 
-....) 
\.;.) 
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Table 12. 31P Chemical Shifts (in ppm) of IP3 a 
[Li+]/mM [Mg2+]/mM pl P4 Ps 
0 0 7.80 9.40 9.12 
10 0 7.89 9.38 9.10 
20 0 7.90 9.31 9.07 
0 2.5 7.77 8.91 8.51 
0 5 7.63 8.69 8.20 
aThe concentration of IP3 in the Na+ form was 2 mM; other conditions were the same as for 
Figure 12. The errors are less than 0.1 ppm 
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IV.IC. Competition Between Li+ and Me2+ for RBC Membrane and ATP 
Many enzymes are activated by Mg2+ including G proteins and adenylate cyclase present 
in RBC membrane (16, 119). Therefore, Mg2+ competition must be considered when studying 
the interaction of Li+ with membranes. 
7Li T 1 measurements were conducted at 37 °C in RBC membrane suspensions (at a 
concentration of 3.0 ± 0.5 mg/ml) in the presence of 0 to 1.0 mM Mg2+. For each Mg2+ 
concentration in RBC membrane suspension, we then varied the u+ concentration between 
1.0 mM and 150 mM. For a fixed Mg2+ concentration (Fig. 13), an increase in Li+ 
concentration resulted in an increase in the 7Li T 1 values because of an increase in the fraction 
of free u+. For a fixed Li+ concentration, an increase in Mg 2+ concentration caused an 
increase in the 7Li T 1 values because of metal ion competition for binding sites in membrane. 
From the observed 7Li T 1 values we calculated by using equation 19 the apparent Li+ binding 
constants in the presence of Mg2+. The Li+ and Mg2+ binding constants to the RBC 
membrane was calculated by using equation 20 and found to be 174 M·1 and 3300 M-1, 
respectively, with a regression coefficient of 0.91. 
7Li T 1 values were also measured for 7. 0 mM ATP solutions containing varying Li+ 
(1.0 - 1000 mM) and Mg2+ (0 - 2.5 mM) concentrations. We fitted the 7Li T 1 relaxation data 
(Table 13) measured for 7. 0 mM ATP solutions containing Li Cl alone and LiCl/MgC12 
mixtures to three different models (see III.3C) to generate binding constants and limiting R 1 
values for Li+ bound to ATP. 
For ATP in the presence of LiCl alone and assuming an R 1 value of 0.05 s·
1 for free 
Li\ the u+ binding constants and the R 1 values for bound u+ were 12 M-
1 and 1.5 s·1 (E2 
= 1.9 x 10-s) for the model based on the LiATP species, 1.0 x 105 M·2 and 0.47 s·1 (I;2 = 4.9 
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Figure 13. 7Li T 1 Values for Membrane Suspensions in Presence of Various Concentrations 
of Mg2+. The Li+ concentrations were in the range of 2 mM to 20 mM, the concentrations 
of Mg+ were 0 (open squares), 0.2 mM (closed diamonds), 0.6 mM (closed squares) and 1.0 
mM (closed circles). Membrane concentration was 3.0 ± 0.5 mg/mL. 
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Table 13. 7Li T1 Values in ATP Aqueous Solutions in the Presence of Various 
C . f M 2+ a oncentrat1ons o g . 
[Mg2+]/mM 
[Li+]/mM 0 0.5 1.0 1.5 2.0 2.5 
1.0 6.4 ± 0.4 8.3 ± 0.4 8.1 ±0.3 8.8 ± 0.7 9.2 ± 0.4 10.2 ± 0.8 
10 6.7 ± 0.1 7.7 ± 0.2 8.8 ± 0.3 9.0 ± 0.3 9.8 ± 0.1 10.2 ± 0.3 
20 7.1 ± 0.1 8.1 ± 0.3 8.9 ± 0.3 9.4 ± 0.2 10.7 ± 0.3 11.3 ± 0.5 
40 7.8 ± 0.2 9.0 ± 0.5 9.4 ± 0.1 9.9 ± 0.2 11.2 ± 0.2 11.5 ± 0.4 
60 8.7 ± 0.3 9.7 ± 0.5 10.4 ± 0.7 10.4 ± 0.1 11.4 ± 0.2 12.7 ± 0.8 
80 9.3 ± 0.6 9.6 ± 0.1 11.1 ± 0.4 11.1 ± 0.2 12.4 ± 0.4 12.9 ± 0.4 
100 9.4 ± 0.2 10.5 ± 0.4 11.3 ± 0.3 11.5 ± 0.3 13.1 ± 0.2 13.4 ± 0.5 
120 10.2 ± 0.6 11.0 ± 0.2 11.7 ± 0.3 11.6 ± 0.4 13.1 ± 0.6 13.8 ± 0.9 
1000 16.6 ± 0.7 16.7 ± 0.8 17.1 ± 0.5 16.9 ± 0.8 16.4 ± 0.4 16.3 ± 0.3 
aThe units of the T 1 values are in seconds. The concentration of ATP was 7 mM, buffered 
in 0.1 M Tris-Cl at pH 7.4. Measurements were conducted at 37 °C. 
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x 10"3) for the model based on the Li2ATP species, and 3.2 x 10 M"' and 0.21 s·' for LiATP 
and 3.2 x 103 M-2 and 1.6 s·' for Li2ATP (E2 = 1.7 x 10-) for the model based on a mixture 
of LiATP and Li2A TP. The E2 values obtained for calculations with the 
7Li data in the 
presence of LiCl alone indicate that the best nonlinear least-squares fit to the 7Li T, data was 
provided by the model based on a mixture of LiA TP and Li2A TP in which the species 
Li2ATP predominates. Based on nonlinear least-squares fitting of 
31P chemical shift data, we 
had previously found that the 2: 1 species also predominated in aqueous solutions of ATP or 
GTP in the presence of Li+ alone (23,120; section IV. lA.c). 
For ATP in the presence of mixtures containing 0.5 mM MgCl2 and varying 
concentrations of LiCl and assuming an R, value of 0.05 s·' for free u+ and a binding 
constant of 2 x 104 M· 1 for MgA TP (23), the Li+ binding constants and the R 1 values for 
bound u+ were 7.3 M-1 and 1.8 s·' (E2 = 1.3 x 10-4) for the model based on the LiATP 
species, 3.8 x 104 M-2 and 0.46 s·' (E2 = 3.0 x 10·3) for the model based on the Li2ATP 
species, and 8.7 x 102 M"' and 0.14 s·' for LiATP and 1.1 x 104 M-2 and 0.13 s·' for Li2ATP 
(E2 = 6.2 x 10"5) for the model based on a mixture of LiATP and Li2ATP. The E2 values 
obtained for calculations with 7Li data in the presence of LiCl/MgCl2 mixtures also indicate 
that the best nonlinear least-squares fit to the 7Li T, data was provided by the model based on 
a mixture of LiA TP and Li2A TP in which the species Li2ATP predominates. Based on 
nonlinear least-squares fitting of 31P chemical shift data, we had previously found that the 2: 1 
species also predominated in aqueous solutions of ATP or GTP in the presence of Li+ /Mg2+ 
mixtures (23, 120). The Li+ binding constants appear to be greater in Li+ /Mg2+ mixtures than 
in the presence of u+ alone. The large error involved in the calculation of the binding 
constants suggests, however, that this difference may not be significant. 
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IV .2. Multinuclear NMR Study of Li+ -Loaded Erythrocytes 
IV.2A. The Effects of Hematocrit on 7Li NMR T1 Values, and on the Rate of Li+ 
Uptake in Human RBC Suspensions 
Figure 14 shows our results for the hematocrit dependence of intra- and extracellular 
7Li+ T 1 values in human RBC suspensions at 37 °C. Whereas the intracellular 
7Li+ T 1 values 
were independent of the hematocrit used, the extracellular 7Lt T 1 values decreased at 84% 
hematocrit. Using a Newman-Keuls statistical test (114), we found that the extracellular 
7Li+ T1 value at 84% hematocrit was significantly lower (p < 0.05) than the values at 11, 33, 
45, and 67% hematocrit; however, the extracellular T1 values in the 11 to 67% hematocrit 
range were not significantly different. For all hematocrits studied, we found that the 
extracellular 7Li+ T1 values were at least three times greater than the corresponding 
intracellular 7Li+ T 1 values. 
Slight, statistically insignificant variations in T 1 values were observed among different 
blood batches. In a separate experiment, the T1 value of 14.8 ± 0.5 s (n=2) for extracellular 
Li+ in Li+ -free RBCs suspended at 85 % hematocrit in an isotonic-choline medium was 
observed. It was not statistically different (Student's t-test, p > 0.05) from that shown in 
Fig. 13 (16.7 ± 1.3 s, n = 4), which was measured for a different blood batch at 
approximately the same hematocrit (84%) and under the same suspensions conditions. 
For the studies of Li+ uptake in RBCs, packed washed RBCs loaded with 3 mM Li+ 
were suspended at either 44 % or 85 % hematocrit in an isotonic medium containing 50 mM 
LiCl, 12 mM choline chloride, 50 mM KCl (shift reagent contribution included), 10 mM 
glucose, 85 mM sucrose, 5 mM Dy(PPP)27-(in the K+ form), and 10 mM HEPES, pH 7.4. 
The areas under the intracellular 7Li NMR resonance curve were measured every hour during 
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Figure 14. Hematocrit Dependence of Intra- (crosses) and Extracellular (squares) 7Li+ T1 
Values for Human RBC Suspensions at 37 °C. The media used for each measurement are 
described in detail in the Methods section. The extra- and intracellular Li+ concentrations 
were 50 mM and 3.0 mM, respectively. The extracellular T1 measurements were obtained 
with 1 transient for each r value, except for the sample at 84% hematocrit for which 2 
transients were used. The intracellular T 1 measurements were obtained with 2 transients for 
each r value, except for samples with 25 % hematocrit for which 4 transients were used. The 
total accumulation time for each T 1 measurement never exceeded 20 min. Each point 
represents the average of at least four experiments performed on separately prepared samples. 
The error bars indicate the range of T 1 values obtained. 
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an 8 h period and were converted into intracellular Li+ concentrations, [Li+]t, with the 
equation (16). 
Figure 15 shows the kinetics of u+ influx in human RBC suspensions at two different 
hematocrits. At the same temperature and for the same initial extracellular Li+ concentration, 
the rise in the intracellular Li+ concentration in fresh RBC suspensions was faster at the lower 
hematocrit. The initial rates of Li+ uptake, which were calculated from the first derivative 
of the curves at time zero, were 1.40 and 1.27 mmol of Li+/L RBC•h at 44% and 85% 
hematocrit, respectively (Table 14A). The time constant for Li+ influx, which was calculated 
from the time dependence of intracellular Li+ concentrations (see III.3B.), was 8.7 hat 44% 
hematocrit and 4.1 hat 85% hematocrit (Table 14A). The time constant that we obtained at 
44% hematocrit is in good agreement with the time constant of 8.5 h reported by Andrasko 
(121) with fresh RBCs suspended at 40% hematocrit in 155 mM LiCI at 34 °C. The 
equilibrium concentration gradient increased with increasing hematocrit; the limiting 
intracellular u+ concentration, [Li+]"" in• decreased, however, with an increase in hematocrit 
whereas the percentage of intracellular u+ remained approximately constant (Table 14A). 
These results are in agreement with those reported previously by us and others using 7Li NMR 
or AA (27,35,87,95). The literature data from reference 109 and corresponding calculated 
values are also listed in Table 14 (B & C). 
IV.2B. Identification of Li+ Bindin2 Sites in Erythrocytes 
IV.2B.a. 7Li Intracellular Relaxation Study in Li+ -Loaded RBCs 
Measurements of intracellular 7Li+ T, and T2 relaxation times for u+ -loaded RBCs are 
summarized in Table 15. For all the intracellular Lt concentrations studied, T, values were 
84 
Figure 15. Time Dependence of RBC Intracellular Li+ Uptake at 37 °C and at 44% (upper 
curve) or at 85% Hematocrit (lower curve). Fresh packed human RBCs are suspended in an 
isotonic medium containing 50 mM LiCl, 12 mM choline chloride, 50 mM KCl (shift reagent 
contribution included), 10 mM glucose, 85 mM sucrose, 5 mM Dy(PPP)/" (in the K+ form), 
and 10 mM HEPES, pH 7.4. 7Li NMR spectra were obtained after 171 scans, requiring a 
total of 1 h. Li+ influx was measured every hour for an 8 h period. Each concentration is 
that at the midpoint for each hour of accumulation time. Each point represents the average 
of two experiments performed on separately prepared samples. The error bars indicate the 
range of intracellular Li+ concentrations obtained. 
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Table 14. Effect of Hematocrit on Li+ Transport Parameters in Human RBC Suspensions 
Hematocrit Time Constant/h Initial Rate of Li+ Equilibrium Concentration [Li+]°" in/mM %Li+°". ID 
Influx (mmol Li+/L RBC.h) Gradient ([Li+]°"
0
j[Li+] 00 in) 
A. Starting [Li+Lu1: 50 mMa 
44% 8.7b l.40 6.7 12.0 10.6 
85% 4.1 c l.27 57.2 5.3 9.0 
B. Starting [Ln0 " 1: l.8 mM at 45% Ht and 50 mM at 85% Ht' 
45% 11.6 0.12 1.5 1.43 4.8 
85% 16.5 0.82 19.8 13.1 22.2 
c. [Ln over entire sample (RBCs + medium): 3.5 mM' 
20% .J .J 1.9 2.1 12.0 
44% .J .J 4.4 l.2 14.0 
85% 8 .J .J 33.3 0.6 15.0 
aCalculated from data shown in our Fig. 15. bE2, the sum of squared deviations, was 5.5 x 10·2 • cE2 was 4.0 x 10·2• ~stimated 
from data published in Fig. 1 of ref. 109. 'Estimated from data published in Fig. 2 of ref. 109. 1Can not be calculated from data 
in ref. 109. 8Estimated by extrapolation of data published in Fig. 2 of ref. 109. 
00 
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Table 15. 7Li T1 and T2 Relaxation Values of Packed Li+-Loaded RBCs a 
Samples 
Regular RBC 
CORBC 
deoxy RBC 
Glycerol 
50:50% (v/v) 
1.0 
1.4 
2.3 
3.5 
3.5 
3.5 
1.5 
T/s 
5.6 ± 0.1 0.21 ± 0.04 
6.0 ± 0.1 0.30 ± 0.03 
6.3 ± 0.1 0.35 ± 0.01 
6.5 ± 0.2 0.46 ± 0.06 
5.9 ± 0.1 0.53 ± 0.01 
6.7 ± 0.1 0.44 ± 0.05 
4.6 ± 0.1 4.0 ± 0.2 
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R (T/T:z) 
24 
20 
18 
14 
11 
15 
1.2 
aAll samples were run at 37 °C, and the concentrations of intracellular Li+ were confirmed 
by atomic absorption. Viscosity of the glycerol sample was 5 cP. 
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much higher than the corresponding T2 values. As the intracellular Li+ concentration 
increased, so did T1 and T2 values because the fraction of free intracellular Li+ also increased. 
These relaxation data are in agreement with those previously reported (122). The large 
difference between T 1 and T2 values indicates that Li+ interactions with a long correlation time 
(116) must be present in Li+ -loaded RBCs. 
The viscosity of the intracellular volume in RBCs is about 5 cP (115). Viscosity alone 
could be responsible for the observed difference in intracellular 7Li+ T 1 and T2• We therefore 
measured 7Li T1 and T2 values for glycerol/water solutions of 1.5 mM LiCl. The viscosity 
of these samples was in the 0. 7 to 5 cP range and was obtained with 0: 100% to 50:50% (v/v) 
glycerol/water mixtures. Unlike RBCs containing 1.5 mM intracellular Li+ in which there 
was a drastic difference between T1 and T2 values (Table 15), for 1.5 mM LiCl in 50:50% 
glycerol/water (with a viscosity of 5 cP) there was only a slight difference between the T1 
(4.6 ± 0.1 s) and T2 (4.0 ± 0.2 s) values. The T/T2 ratio obtained for the viscosity-adjusted 
1.5 mM LiCl solution was 1.2, which is considerably less than the T/T2 ratio observed for 
RBCs loaded with 1.4 mM intracellular Li+ (20; see Table 15). The values that we obtained 
for Li+ -containing glycerol/water mixtures are in agreement with previously reported data 
(121). The large difference in intracellular RBC 7Li+ T 1 and T2 values is therefore not due 
to viscosity effects. 
7Li T1 and T2 for packed deoxyRBC and packed CORBC were also measured. The 
oxygenation state of Hb was checked by 31P NMR spectra (Fig. 16). N2 treated RBCs were 
paramagnetic, showed broad line shape and downfield shifted 31P NMR resonances (Fig. 16C), 
while the opposite trend was observed in CO treated RBCs (Fig. 16B). In packed RBCs 
loaded with 3.5 mM Li+, the T1 and T2 values for u+-loaded deoxyRBC were 6.7 ± 0.1 s 
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Figure 16. 31P NMR Spectra of Packed RBCs in Various Oxygenation States. TMP was 
used as external reference and spectra line broadening was 3.0 Hz. 
(A) Regular RBCs; (B) CORBCs; (C) DeoxyRBCs. 
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and 0.44 ± 0.05 s (R = 15; n = 2), whereas the NMR relaxation parameters for Lt-
loaded CORBC were: T1 = 5.9 ± 0.1 s, T2 = 0.53 ± 0.01 s (R = 11; n = 2). However, 
the 7Li T2 and R values found in packed Li+ -loaded CORBCs are slightly larger and smaller, 
respectively, than the values obtained in packed Li+ -loaded deoxyRBCs and oxygenated RBCs 
(Table 15) suggesting that the paramagnetic relaxation induced by deoxyHb is small. 
Oxygenated u+-loaded RBCs may contain trace amounts of paramagnetic deoxyHb and 
metHb; not surprisingly, the T2 and R values of oxygenated RBCs are intermediate between 
those observed for CORBCs and deoxyRBCs. Because the large difference in intracellular 
7Li T 1 and T2 values was present in packed u+ -loaded RBCs regardless of the state of 
oxygenation, we conclude that 7Li NMR relaxation in RBCs is not controlled by paramagetic 
relaxation induced by high-spin Fe2+ or by Fe3+ present in deoxy Hb or metHb, respectively. 
IV.2B.b. Interactions of Li+ with RBC Components 
RBC is most often thought of as a packet of hemoglobin. COHb is diamagnetic and 
is an irreversible analogue of oxy Hb, while deoxy Hb and metHb are paramagnetic. The 
oxygenation states of Hb were characterized by UV-Vis spectrophotometry. A red shift in 
the Amax of the Soret band was observed when converting the oxy form (415 nm) to the CO 
form (419 nm), while that of the deoxy form had a blue shifted band (430 nm). Due to the 
difficulty in preparing concentrated Hb, the concentration used (2. 7 mM per tetramer) was 
half the value of the physiological concentration (5.4 mM). The viscosity of the Hb solution 
was adjusted to 5 cP with glycerol. 
The Hb results are shown on Table 16. By increasing the concentration of Li+ from 
1.5 to 8 mM, the T 1 and T2 values stayed almost constant for all oxygenation states. 
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Compared with deoxyHb and COHb, both the T1 and the T2 values for metHb were lower 
which may be the result of higher paramagnetism induced by the high spin Fe3+ center. 
However, the difference between T1 and T2 relaxation values for different forms of Hb was 
essentially the same. The R values were small, and were independent of Li+ concentration 
which indicated that u+ bound weakly to Hb. This agrees with published results (122,123). 
7Li T 1 and T2 relaxation times were also measured for ATP, DPG (Table 17), spectrin 
(Table 18) and membrane (Table 19). Table 20 is a summary of 7Li relaxation in RBC and 
its components at 1.5 mM Li+ concentration. The T/T2 ratio ranged from 1.3 to 1.6 in ATP 
and DPG at physiological concentrations, implying that at the Li+ concentrations typically 
present in Li+ -loaded RBCs Li+ binds weakly to ATP and DPG. The T/T2 ratio of spectrin 
(1.9 mg/ml) was around 4, while it was in the range of 30 to 50 for membranes at the same 
protein concentration, suggesting weak u+ binding to spectrin. In solutions of ATP, DPG, 
and spectrin, an increase in Li+ concentration resulted in increases of both T1 and T2 values; 
this effect was also observed for Li+ -loaded RBCs (Table 15) and is due to an increase in the 
mole fraction of free Li+. The absolute values of the T 1 and T2 values observed in Hb and 
spectrin solutions are significantly larger than those observed in ATP and DPG solutions; the 
higher T 1 and T2 values are associated with the longer correlation times for Li+ bound to the 
high molecular weight proteins Hb and spectrin. 
The large difference in intracellular 7Li T1 and T2 relaxation values characteristic of Li+ -
loaded RBCs is also present in unsealed RBC membrane suspensions whose viscosity was 
adjusted to 5 cP with glycerol (Table 19), indicating that binding of Li+ to the RBC membrane 
is responsible for the unique relaxation behavior of Li+ -loaded RBCs. The NMR parameters 
for a 1.5 mM u+ -containing RBC membrane suspensions (2.0 mg/mL) whose viscosity was 
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Table 16. 7Li T1 and T2 Relaxation Values of 2.7 mM Hemoglobin Solutions (n=2) a 
Sample T/s T/s 
COHb 1.5 4.5 ± 0.5 2.0 ± 0.1 2.2 
3.0 5.3 ± 0.4 2.0 ± 0.3 2.7 
5.0 5.0 ± 0.6 2.0 ± 0.3 2.5 
8.0 4.9 ± 0.1 2.1 ± 0.1 2.3 
MetHb 1.5 4.2 ± 0.3 1.5 ± 0.1 2.8 
3.0 4.4 ± 0.1 1.7 ± 0.1 2.6 
5.0 4.3 ± 0.2 1.6 ± 0.1 2.7 
8.0 4.4 ± 0.4 1.7 ± 0.1 2.6 
Deoxy Hb 1.5 4.7 ± 0.1 2.0 ± 0.2 2.4 
3.0 4.8 ± 0.1 2.1 ± 0.2 2.3 
5.0 4.6 ± 0.2 2.0 ± 0.1 2.3 
8.0 5.0 ± 0.2 2.1 ± 0.1 2.4 
a All samples were buffered at pH 7.4; viscosities were adjusted by glycerol to approx. 5 cP, 
and NMR measurements were run at 37 °C. 
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Table 17. 7Li T1 and T2 Relaxation Values in Aqueous Solutions of ATP and DPG (n=2t 
Sample T/s T/s 
2.0 mM ATP 1.5 0.85 ± 0.03 0.53 ± 0.03 1.6 
3.0 0.98 ± 0.03 0.66 ± 0.00 1.5 
5.0 1.08 ± 0.01 0.69 ± 0.09 1.6 
8.0 1.22 ± 0.02 0.92 ± 0.00 1.3 
5.4 mM DPG 1.0 1.17 ± 0.01 0.76 ± 0.05 1.5 
3.0 1.18 ± 0.02 0.73 ± 0.05 1.6 
5.0 1.17 ± 0.09 0.77 ± 0.04 1.5 
8.0 1.25 ± 0.03 0.94 ± 0.10 1.3 
4Experimental conditions were the same as for Table 16. 
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Table 18. 7Li T1 and T2 Relaxation Values of Spectrin Solutions (n=2) a 
T/s 
w/o glycerol 
1.5 16.7 ± 0.5 6.2 ± 0.7 2.7 
3.0 16.4 ± 0.3 6.1 ± 0.7 2.7 
5.0 15.8 ± 0.1 6.6 ± 0.3 2.4 
w/ glycerol adjusted to 5 cP 
1.5 3.0 ± 0.1 0.68 ± 0.10 4.4 
3.0 3.3 ± 0.2 0.77 ± 0.12 4.9 
5.0 3.7 ± 0.2 0.95 ± 0.20 3.9 
0 The protein concentration of spectrin was 1.9 mg/mL. The NMR samples were run at 37 
°C, and buffered at pH 7.6 with the extraction buffer (0.3 mM sodium phosphate). 
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Table 19. 7Li T1 and T2 Relaxation Values of RBC Membrane Suspensions (n=2) a 
T/s T/s 
w/o glycerol 
1.5 9.1 ± 0.1 0.13 ± 0.02 70 
3.0 11.3 ± 0.2 0.17 ± 0.03 66 
5.0 12.7 ± 0.2 0.26 ± 0.03 49 
8.0 14.5 ± 0.2 0.33 ± 0.02 44 
w/ glycerol (adjusted to 5 cP) 
1.5 3.4 ± 0.1 0.07 ± 0.01 49 
3.0 4.2 ± 0.1 0.08 ± 0.01 52 
5.0 4.7 ± 0.2 0.13 ± 0.01 39 
8.0 5.1 ± 0.1 0.17 ± 0.02 30 
aThe protein concentration of RBC membranes was 2.0 mg/mL. The NMR samples were run 
at 37 °C, and buffered at pH 8 with the extraction buffer 5 mM HEPES. 
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Table 20. 7Li Relaxation Values for RBCs and Its Components at 1.5 mM Li+ 
Concentration (n=2) a 
T/s T/s Concentration 
RBC 6.0 ± 0.1 0.30 ± 0.03 20 
ATP 0.85 ± 0.03 0.53 ± 0.03 1.6 2.(f 
DPG 1.2 ± 0.1 0.82 ± 0.02 1.5 5.4c 
COHb 4.5 ± 0.5 2.0 ± 0.1 2.2 2.7b 
deoxy Hb 4.7 ± 0.1 2.0 ± 0.2 2.4 2.7b 
metHb 4.2 ± 0.3 1.5 ± 0.1 2.8 2.7b 
spectrin 3.0 ± 0.1 0.68 ± 0.10 4.4 1.9c 
RBC membrane 3.4 ± 0.1 0.07 ± 0.01 49 2.0c 
glycerol 4.6 ± 0.1 4.0 ± 0.2 1.2 50:50% (v/v) 
°The viscosities of all samples were adjusted to 5 cP with glycerol. All NMR samples were 
run at 37 °C. ATP, DPG and glycerol were buffered with 10 mM Tris-Cl to pH 7.4; RBCs, 
Hb, spectrin and membranes were suspended in the same media as the extraction buffer. 
~he concentration unit is mM. cThe unit is mg/mL protein. 
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not adjusted with glycerol were: T 1 = 9.1 ± 0.1 s, T2 = 0.13 ± 0.02 s (R = 70; n = 2). 
The globular Hb protein is present in RBCs but absent in RBC membrane suspensions; the 
larger R values observed in RBC membrane suspensions relative to those found with intact 
RBCs, are presumably due to differences in viscosity between the two samples, and additional 
Li+ binding sites in packed RBCs. 
IY.2B.c. Li+ Interaction with IOY and ROY 
To determine which side of the RBC membrane contributes the most toward Li+ 
binding, we measured 7Li T 1 values for IOY and ROY suspensions containing u+ in the 2.0 
to 9.0 mM range (Table 21, Figure 17). The preparations of the two types of RBC vesicles 
were characterized by glyceraldehyde-3-phosphate dehydrogenase and acetylcholine esterase 
sidedness assays. Whereas glyceraldehyde-3-phosphate dehydrogenase is located in the inner 
leaflet of the RBC membrane, acetylcholinesterase is located in the outer leaflet. The 
percentages of sidedness accessibility that we found (see IIl.2.G.) agree with literature values 
(104). We also added a shift reagent, 3.0 mM Dy(PPP)t, to the RBC vesicle suspensions 
and observed only one 7Li NMR resonance; the 7Li T1 data obtained in RBC vesicle 
suspensions are therefore due to extravesicular Li+, and not due to an average of intra- and 
extravesicular Li+. 
For the same extravesicular Li+ and membrane concentrations, the T1 values observed 
in ROY suspensions are two to three times larger than those found in IOY suspensions (Figure 
17). Because ROYs were generated from a Mg2+ -containing buffer (0.5P8-0.1Mg), Mg2+ may 
compete with Li+ for binding sites on the surface of ROYs; this metal ion competition could 
provide an alternative explanation for the larger T1 values observed in ROY suspensions. 
Table 21: 7Li T 1 Relaxation Values for IOV and ROV (n=4) 
T/s (IOV) 
2 3.2 ± 0.3 
3 3.8 ± 0.4 
5 4.5 ± 0.4 
7 5.3 ± 0.5 
9 5.9 ± 0.5 
Prot.(mg/mL) 3.5 ± 0.3 
% Sidedness 80 ± 8 
Accessibility" 
% Sidedness 19 ± 4 
Accessibilityb 
a Glyceraldehyde-3-phosphate dehydrogenase 
b Acetylcholinesterase 
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T/s (ROV) 
9.3 ± 0.7 
10.3 ± 1.0 
10.9 ± 0.8 
11.2 ± 0.7 
11.5 ± 0.6 
3.5 ± 0.7 
21 ± 3 
94 ± 2 
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Figure 17. 7Li T 1 Values for Li+-Containing IOV (closed circles) and ROV (open circles). 
The data reported are an average of four separately prepared samples. The membrane protein 
concentrations in the IOV and ROV preparations were 3.5 ± 0.3 and 3.5 ± 0.7 mg/mL, 
respectively. 
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To rule out this latter possibility, we conducted a control experiment where we added 0.1 
mM MgS04 to an IOV suspension containing 7.0 mM u+. Although the T1 value increased 
by 15% (from 5.3 s to 6.1 s), the T1 value observed in Mg2+-containing IOV suspensions (6.1 
s; n = 2) was significantly shorter than that observed for ROV suspensions containing 7.0 
mM Li+ (11. 2 s; n = 4). The large 7Li T 1 values observed in RO V suspensions relative to 
IOV suspensions indicate weaker binding of Li+ to the outer leaflet of the RBC membrane 
than to the inner leaflet; the difference in 7Li T 1 values in ROV and IOV suspensions is not 
due to competition between Li+ and Mg2+ for binding sites in the RBC membrane. 
IV.2B.d. 7Li Relaxation Behavior in RBC Membrane Suspensions 
To understand the relaxation behavior of Li+ in the presence of RBC membrane, 
partially relaxed 7Li NMR spectra of 20 mM LiCl in the presence of 6.0 ± 0.2 mg/mL of 
unsealed RBC membrane were measured (Fig. 18). For a single Lorentzian line, the ratio 
of tl.111r/tl.11 112 should be approximately 2.7 (80). At a pulse interval, r, of 0.75 s, the 
t:J.11 11/ t:J.11 112 value of 3.4 is larger than the theoretical value of 2. 7; the inverted resonance 
observed for r = 0. 75 s is therefore composed of broad and narrow components. Similarly, 
the completely relaxed 7Li NMR resonance observed for r = 11.0 s yields a t:J.11 11/tl.11 112 value 
of 3.5 also indicating biexponential relaxation for the 7Li nucleus in the presence of RBC 
membrane. As the negative intensity decreases, we observed that the broad (or fast) 
component nulled and the tl.11 11/ tl.11 112 value reached a minimum for a r value of 6.3 s; on 
division by In 2 it gives a T 1r value of 9.0 s. For r = 6.3 s, only the narrow (or slow) 
component was observed; a value of 0.21 s for T2s was calculated by fitting the t:J.11 112 value 
into the equation T2• = (7l'11112r1• For a r value of 8.0 s, the tl.11 11/t:J.11 112 value is close to 2.7 
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Figure 18. Partially Relaxed 7Li NMR Spectra in RBC Membrane Suspension. Suspension 
contained 20 mM LiCl, 80% (v:v%) unsealed RBC membrane (6.0 ± 0.2 mg/mL) and 20% 
of 5H8 (prepared by DzO). The pulse sequence (D - 180° - T - 90°)n was used for recording 
the 7Li NMR spectra. The interpulse delay (r) values are indicated by the side of the spectra, 
and the preacquisition delay (D) values were ten times the value of T1• Each spectrum was 
obtained by averaging 30 transients (n). 
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indicating that the narrow component reached its null point making only the broad component 
visible; the Ti. and T2f values calculated from the r value of 8.0 s and the d11 112 were 11.5 s 
and 0.06 s, respectively. Whereas biexponential relaxation was observed for membrane 
suspensions containing 20 mM LiCl, only one relaxation component with Lorentzian line 
shape was observed in membrane suspensions (with the same protein concentration) containing 
150 mM LiCl or in a glycerol/water mixture containing 150 mM LiCl (no membrane). 
Therefore, a large fraction of bound u+ must be present in the membrane suspension to 
observe biexponential relaxation. 
We measured the areas of the 7Li NMR resonances and the T 1 values in RBC 
membrane suspensions (at a protein concentration of 3.0 ± 0.5 mg/mL) containing Li+ in the 
range of 2.0 mM to 22.0 mM (Figure 19). The areas of the 7Li NMR resonances were 
directly proportional to the Li+ concentrations present in the RBC membrane suspension and, 
in the presence of RBC membrane, the areas were at least 95 % of the areas observed in the 
absence of membrane indicating that there were no significant changes in the 7Li NMR 
observable pool of Li+ ions. From the observed 7Li T 1 values, which are a weighted average 
of Tlf and T 1• values, we calculated the binding constant of Li+ to the RBC membrane by 
using equation 19; the Kb value was 215 ± 36 M-1 (r 2.. 0.95; n = 10). 
IV.3. Relationship Among Na+ /Li+ Countertransport Rates, Phospholipid Composition, 
and Li+ Binding to Human RBC Membranes from Bipolar Patients Receiving 
Lithium Carbonate 
IV .3A. Demoeraphy of Patients and Controls 
Whole blood from ten bipolar patients who were receiving lithium carbonate and from 
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Figure 19. James-Noggle Plot of RBC Membrane Suspension Containing Li+. The 
membrane protein concentration was 3.0 ± 0.5 mg/mL. 
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ten normal individuals were obtained from the Department of Psychiatry, Loyola University 
Medical Center, Maywood, IL. Each bipolar patient was matched to a normal individual 
according to gender, race, age, and weight. Patients were diagnosed according to the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IIIR, 1990) (99). The patients 
in this study received between 300 and 2100 mg of lithium carbonate per day and had been 
taking lithium for a minimum of 3 weeks or for as long as 17 years. Some patients were 
taking other psychotropic drugs, including phenothiazines and benzodiazepines. Because Na+ -
Li+ exchange rates are related to the occurrence of hypertension (95,96), blood pressure was 
measured at the time of blood drawing, and individuals suffering from hypertension were 
excluded from the study. Tables 22 and 23 are the demography of patients and controls, 
respectively. 
IV .3B. Na+ /Li+ Countertransport Rates 
Washed packed RBCs (2 ml) were incubated in 10 ml u+ -loading medium containing 
150 mM LiCl, 10 mM glucose, and 10 mM HEPES, pH 7.4 at 37°C for 3 hours. After 
incubation in the Li+ -containing medium, to remove extracellular Li+ from the Li+ -loaded 
RBCs we washed the cells five times by centrifugation at 7 ,000 g for 5 min in the choline 
wash solution. The u+ -loaded RBCs (0.6 ml) were suspended in 6 ml in either isotonic Na+ 
medium (150 mM NaCl, 10 mM glucose 0.1 mM ouabain, 10 mM HEPES, pH 7.4) or 
choline medium (100 mM choline chloride, 85 mM sucrose, 10 mM glucose, 0.1 mM 
ouabain, 10 mM HEPES, pH 7.4) at 37 °C for a 75 min-period measurement of the rates of 
Na+-u+ exchange (95) by means of AA. Aliquots were taken every 15 min from each of the 
Table 22. Demography of Bipolar Patients0 
Patient Sex Race Age 
Pl F w 69 
P2 F B 43 
P3 M w 40 
P4 M w 53 
PS M w 57 
P6 M w 22 
P7 M w 34 
pg M w 36 
P9 M w 30 
PIO M w 62 
Weight 
(LBs) 
242 
230 
159 
205 
163 
132 
205 
200 
151 
193 
B l o o d 
Pressure 
124/60 
125/75 
138/73 
143/90 
171/98 
120/80 
131/69 
140/98 
100170 
120170 
[Li+]. 
(mM) 
0.074 
0.010 
0.162 
0.133 
0.210 
0.196 
0.173 
0.167 
0.258 
0.318 
Smoker Inpatient 
N y 
N N 
y y 
y y 
y y 
y N 
y y 
y y 
y y 
y N 
0 M = Male, F =Female, W = White, B = Black, Y = Yes, N = No, [Li+] = starting intracellular Li+ concentration 
....... 
~ 
Table 23. Demography of Matched Controlsa 
Controls Sex Race 
Cl F w 
C2 F B 
C3 M w 
C4 M w 
C5 M w 
C6 M w 
C7 M w 
C8 M w 
C9 M w 
CJO M w 
a Abbreviations are the same as for Table 21. 
Age 
65 
42 
43 
52 
55 
22 
37 
39 
28 
63 
Weight 
(LBs) 
149 
127 
189 
180 
197 
185 
210 
151 
184 
185 
B I o o d 
Pressure 
134178 
112172 
130/80 
120175 
160/100 
135/80 
124/90 
110170 
1401102 
160/70 
Smoker 
N 
y 
y 
N 
N 
N 
N 
y 
N 
y 
-
-0 
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Li+-loaded RBC suspensions and collected into precooled polyethylene tubes and centrifuged 
at 10,000 g for 2 min at 4 °C, and the supernatants were collected and analyzed by AA. Li+ 
standards (10 - 200 µM Li+) prepared in both Na+ and choline media were used for 
construction of calibration curves. Li+ transport in the choline medium occurred via the leak 
pathway; that observed in the Na+ medium was mediated by both the Na+ -Li+ exchange and 
the leak pathway. The rates of Na+ -Li+ exchange were obtained by subtraction of the 
measured rates of Li+ transport in the choline medium from those measured in the Na+ 
medium (27,95). 
Tables 24 and 25 list the rates of Na+ -Li+ exchange in Li+ -loaded RBCs, the 
phospholipid composition, and the Li+ binding constants for the RBC membranes of the ten 
bipolar patients receiving lithium carbonate and the ten matched normal individuals, 
respectively. 
The rates of RBC Na+-u+ exchange measured by AA were found to be significantly 
lower for the ten bipolar patients receiving lithium carbonate than for the ten normal 
individuals (0.14 ± 0.02 mmol Li+ /L of RBCs x h vs. 0.21 ± 0.06, mean ± SD, paired 
Student's t-test, p < 0.003, n = 10). The top two Na+-Li+ exchange rates shown in each 
table are for female, whereas the remaining values are for males; the exchange rates for 
female were lower than for males in the patient and control groups. These results are in 
agreement with those previously reported (27,35,95,124-127). 
IV .3C. Interaction of Li+ with RBC Membranes 
We measured 7Li T 1 values in the presence of isolated RBC membranes (containing Li+ 
in the 1.0 - 15 mM range) from lithium-treated patients and matched normal individuals at 
Table 24. Na+-Li+ Exchange Rates (in mmol Li+/L RBCs x h), Phospholipid Composition(%), and Li+ Binding Constants (M-1) 
to RBC Membranes of Bipolar Patients Receiving Lithium Carbonate. 0 
Patient No. Na+-u+ PC PS PI PE Sph Kb 
Pl 0.12 31.5 17.3 0.8 25.1 25.4 314 
P2 0.13 29.6 15.7 l.3 26. l 27.3 333 
P3 0.12 32.1 17. l 0.8 26.6 23.6 291 
P4 0.11 34.3 15.8 0.9 25.2 23.8 285 
P5 0.14 28.0 17.4 0.6 30.9 23.0 326 
P6 0.20 33.7 18.7 0.7 26.7 20.3 243 
P7 0.14 28.5 16.0 l.O 27.0 27.5 362 
pg 0.12 30.0 15.7 0.4 30.3 23.7 297 
P9 0.14 26.5 18.1 0.8 28.4 26.2 285 
PIO 0.14 29.2 17.8 0.6 31.4 21. l 247 
Averageb 0.14 ± 0.02 30.3 ± 2.5 17.0 ± 1.1 0.8 ± 0.2 27.8 ± 2.3 24.2 ± 1.1 298 ± 37 
-
0 The r2 values are greater than 0. 98 and 0. 95, respectively, for the rates of Na+ -Li+ exchange and for Kb values. The areas under 
the 31 P NMR resonances were normalized to 100% for the five major classes of phospholipids. The accuracy of the percentage 
composition for PC, PS, PE, and Sph is within ± 10% of the values listed in the table, whereas the accuracy of the PI values is 
within ± 20% because of baseline noise (108). For abbreviations, see text. bValues expressed as mean ± standard deviation. 
....... 
....... 
N 
Table 25. Na+ -Li+ Exchange Rates (in mmol Li+ /L RBCs x h), Phospholipid Composition (%), and Lt Binding Constants (M-1) 
to RBC Membranes of Matched Normal Individuals. 0 
Control No. Na+ -Li+ PC 
Cl 0.15 28.8 
C2 0.15 31.1 
C3 0.32 25.9 
C4 0.23 29.5 
cs 0.19 29.1 
C6 0.26 31.3 
C7 0.17 28.3 
C8 0.19 31.7 
C9 0.18 29.3 
ClO 0.26 31.9 
Averageb 0.21 ± 0.06 29.7 ± 1.9 
-
0 and b Same as for Table 23. 
PS PI 
17.0 0.7 
13.7 0.6 
16.2 0.4 
15.7 1.1 
17.7 1.1 
14.9 1.2 
15.1 1.4 
16.9 0.6 
14.7 0.5 
16.9 0.9 
15.8 ± 1.2 0.9 ± 0.3 
PE Sph 
29.2 24.2 
24.8 29.9 
32.5 25.6 
28.3 25.4 
27.8 24.3 
29.1 23.4 
29.7 25.4 
24.7 26.1 
31.7 23.4 
28.8 22.0 
28.7 ± 2.5 25.0 ± 2.1 
Kb 
276 
185 
224 
166 
178 
228 
253 
213 
183 
243 
215 ± 36 
...-
...-
\.>) 
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the same membrane protein concentration (2.9 ± 0.8 mg/mL). Figure 20 shows the 7Li T1 
values observed upon titration with Li+ of the unsealed membrane prepared from the RBCs 
of a lithium-treated patient and that from the RBCs of a matched normal individual. A 
statistically significant difference (p < 0.05) in 7Li T1 values was observed betweert the 
samples from the patient and the normal individual for Li+ concentrations ;;::; 15 mM. Similar 
results were obtained for the remaining matched pairs of patients and normal individuals. Li+ 
ions are in fast exchange on the 7Li NMR time scale; the observed 7Li T 1 values therefore 
represent the weighted average of free Li+ in the suspension medium and Li+ bound to the 
RBC membrane. Free nuclei have large T1 values, whereas those that are bound to the RBC 
membrane have relatively small T1 values. The T 1 values for 
7Li increased in the presence 
of increasing concentrations of Li+ in membrane samples of both patients and normal 
individuals (Figure 20) because of increasing fractions of free Li+. These observations 
confirm that 7Li T 1 values are dependent on Li+ binding to RBC membranes. For a given Li+ 
concentration, the amount of Li+ bound to the T 1 values of 
7Li were greater for membrane 
samples (with the same protein concentration) from normal individuals than for samples from 
matched lithium-treated patients. For a given Li+ concentration, the amount of Li+ bound to 
the same amount of RBC membrane was larger for patients than for normal individuals. The 
Li+ binding constants, as calculated from James-Noggle plots (see III.3C. and Fig. 19), to the 
RBC membranes from bipolar patients receiving lithium carbonate were significantly higher 
than those for normal individuals (298 ± 37 M-1 vs. 215 ± 36 M-1, p < 0.001, n = 10). 
The observed 7Li T 1 data and the calculated Kb values (Tables 24 & 25) indicate that Li+ has 
a stronger affinity for RBC membranes of lithium-treated patients than for those of normal 
individuals. 
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Figure 20. 7Li T1 Values of RBC Membrane Samples from Patient 4 (open squares) and 
Normal Individual 4 (closed diamonds) in the Presence of Increasing Concentrations of Li+. 
The numbering for the samples is the same as for Tables 12 and 13. The membrane protein 
concentration for this paired samples was 3.5 ± 0.1 mg/mL. 
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IV .3D. Phospholipid Composition Analysis 
Figure 21 shows a typical 31P NMR spectrum of a phospholipid extract from a human 
RBC membrane. The assignments of the phospholipid resonances are indicated in the 
spectrum and were obtained as described in Section 111.21. The unassigned resonances 
downfield from the PE resonances are presumably due to derivatives of lysophosphatidic acid 
(107). Two types of PE and PC are clearly resolved in 31P NMR spectra of phospholipid 
extracts of human RBC membranes. Regular PE or PC has alkyl ethers on the glyceride 
backbone, whereas PE plasmalogen (PEp) has an alkenyl ether and AAPC is an alkylacyl 
derivative of PC. The resolution of the two forms of PE and PC in 31P NMR spectra was 
also observed in phospholipid extracts of other cell membranes (107, 108, 128). We added the 
areas under the two PE resonances to obtain the total PE composition. When one uses the 
areas under the 31P NMR resonances to measure phospholipid composition, it is important to 
ensure that all the resonances are fully relaxed under the conditions used for recording the 
NMR spectrum. We compared the relative intensities of the signals obtained when using a 
delay between successive radiofrequency pulses of 4.0 s and 10 s. No statistically significant 
difference occurred between the percentage phospholipid compositions obtained with the two 
instrument settings, indicating that the experimental conditions specified in the caption to 
Figure 21 result in reliable quantitation of phospholipids in the RBC membrane. Edzes et 
al. (108) reported that, by increasing the percentage of chloroform in the solvent mixture, 
one can shift the PS resonance away from the PE/Sph envelope. We tested two different 
chloroform/methanol/water solvent mixtures (in ratios of 100:40: 10, Fig. 21A, and 125:8:3, 
Fig. 21B) and found that, by increasing the percentage of chloroform in the solvent mixture, 
one can shift the PS resonance upfield and past the Sph resonance and completely resolve the 
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Figure 21. 31P NMR Spectra of Phospholipid Extracts from Human RBC Membrane. The 
solvent mixture ratio of chloroform/methanol/0.2 mM EDTA was (A) 100:40:10 and (B) 
125:8:3. The assignments of each resonance to the various phospholipids are shown on the 
spectrum. The symbols are: AAPC, alkylacyl PC; PC, phosphatidyl choline; PE, 
phosphatidyl ethanolamine; PEp, PE plasmalogen; PI, phosphatidyl inositol; PS, phosphatidyl 
serine; Sph, sphingomyelin. The positions of the resonances (chemical shifts) are reported 
relative to that of PC set at -0.84 ppm (parts per million). The spectrometer settings used for 
recording the one-dimensional spectrum were: pulse width, 7 µs (60° flip angle); acquisition 
time, 1.4 s; delay between successive radiofrequncy pulses, 4.0 s; number of scans, 10,000; 
spectral width, 1,050 Hz; spinning rate, 16 Hz; high power proton broadband decoupling, 55 
dB. 
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PS resonance from other 31P signals. We found no statistically significant difference in 
phospholipid composition between the two different solvent mixtures. The 125:8:3 ratio is 
recommended for future studies of phospholipid extracts of human RBC membranes because 
it simplifies the integration of the 31P NMR spectra. 
By using 31P NMR spectroscopy, we found that the PS content in phospholipid extracts 
from RBC membranes was significantly lower for lithium-treated patients than for normal 
individuals (17.0 ± 1.1 % vs. 15.8 ± 1.2%, paired Student's t-test, p < 0.05, n = 10). No 
significant differences were found between the patients and normal individuals for the anionic 
phospholipid PI and for the neutral phospholipids PE, PC, and Sph. 
IV .3E. Correlation Analysis 
Table 26 are data for a Pearson product-moment correlation. Significant positive 
correlations between the patient and control groups for the PS (r = 0.46, p < 0.04) and~ 
(r = 0.77, p < 0.001) values, and significant negative correlations for the rates of Na+-u+ 
exchange (r = -0.67, p < 0.001). These correlations are in agreement with the conclusions 
from the paired Student's t-test mentioned above. The rates of RBC Na+-u+ exchange 
measured under standard assay conditions were significantly negatively correlated (r = -0.56, 
p < 0.01) with the Li+ binding constants calculated from T 1 values measured in the presence 
of RBC membranes. No significant correlations were found between the u+ binding constants 
or the rates of Na+ -Li+ exchange and the other phospholipids percentages. 
Table 26. Pearson Product Moment Correlation For Lt Binding and Transport Parameters in RBCs from Bipolar Patients Receiving 
Lithium Carbonate and from Matched Normal Individuals.a 
Type b PC PS PI PE Sph Na+-u+ Kb 
Typeb 1.00 
PC 0.15 1.00 
PS 0.46 -0.02 1.00 
PI -0.11 0.07 -0.17 1.00 
PE -0.19 -0.64 -0.01 -0.29 1.00 
Sph -0.18 -0.30 -0.50 0.17 -0.42 1.00 
Na+-u+ 
-0.67 -0.19 -0.13 0.01 0.38 -0.14 1.00 
Kb 0.77 -0.05 0.25 0.08 -0.13 0.05 -0.56 1.00 
acorrelation coefficients .L 0.4 are considered significant (p ~ 0.05). ~ype refers to a comparison of parameters between lithium-
treated bipolar patients and normal matched individuals. 
....... 
N 
....... 
CHAPTER V 
DISCUSSION 
V.1. Competition Between Li+ and Mg2+ for the Substrates of Second Messenger 
Systems, and RBC Membrane 
Because of the similarity between Li+ and Mg2+, it is possible that Li+ exerts its 
pharmacological effects by competing with Mg2+ for its enzyme binding sites in second 
messenger systems. G proteins and adenylate cyclase are magnesium activated, and the 
phosphoinositide turnover system which is G protein activated also has potential binding sites 
for cations (14,16). Therefore, I addressed the question of competition between u+ and 
Mg2+ for substrates of the second messenger systems, including GTP, GDP, AMP, cAMP and 
IP3• pH, ionic strength, and temperature are factors on which metal ion binding to nucleotides 
are known to be dependent (129); we controlled all these factors in our experiments except 
for IP3 • The bulky organic cations Tris and tetramethylammonium were selected to adjust pH 
and ionic strength because they would not compete with metal cation binding to the enzymes. 
Because of the stacking property of nucleotides (130) and the low sensitivity of the NMR 
measurement, the concentrations of the nucleotides were in the range of 5 mM to 10 mM. 
The concentration of IP3 was between 2 mM and 4 mM. 
In aqueous solutions of AMP, cAMP, GTP and GDP, we investigated whether metal 
ion binding to nucleotides takes place via the base, sugar, or phosphate moiety. We probed 
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123 
metal ion binding to the base and sugar domains by using 1H and 13C NMR, whereas we 
studied metal ion binding to the phosphate groups by 31P NMR. We also studied competition 
between Li+ and Mg2+ ions for binding sites in guanine nucleotides by using 7Li NMR 
relaxation measurements and 31P NMR chemical shifts. 
7Li spin-lattice relaxation values decreased with increasing concentration of GTP or 
GDP (Figure 6), confirming that 7Li T1 values are dependent on u+ binding to guanine 
nucleotides. This behavior was similar to that previously reported for ATP and ADP (23). 
In the presence of increasing concentrations of Mg2+, the 7Li T, values increased because of 
displacement of Li+ by Mg2+ from GTP- and GDP-binding sites, which indicated that 
simultaneous binding of Li+ and Mg2+ to GTP and GDP had occurred, in a manner analogous 
to what were observed for ATP and ADP (23). However, no differences were observed in 
LiCl solutions upon addition of AMP or cAMP; the interaction between u+ and AMP or 
cAMP was too weak to be detected by relaxation measurements. 
No significant chemical shift changes were observed in the 1H and 13C NMR spectra of 
GTP and GDP upon addition of saturating amounts of u+ and Mg2+ (Table 2); no direct 
metal ion binding to the base or sugar moieties of GTP or GDP was present. The small 13C 
chemical shift changes observed are probably due to proximity of metal ions to the sugar or 
base domains, or to a change in nucleotide conformation upon addition of metal ions. Similar 
13C NMR results were obtained with aqueous solutions of cAMP and AMP. 
By using 31P NMR spectroscopy, downfield shifts of the phosphate resonances were 
observed upon addition of metal ions to GTP or GDP solutions. This probably occurred 
from polarization of the electron density away from the phosphorus atoms when metal cations 
were bound to the phosphate groups of GTP or GDP. The shifts experienced by the a-
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phosphate resonance were very small, while the -y-phosphate resonance, and to a greater 
extent that of the 13-phosphate, moved downfield. Therefore, the a-phosphate resonance was 
used as an internal standard; the chemical shift separation between a- and 13-phosphate 
resonances of GTP or GDP (oaiJ) reflects the extent of metal ion binding to GTP and GDP. 
As shown in Figure 9, the value oaiJ of GTP decreased in the presence of saturating 
concentrations of either Li+ or Mg2+. An intermediate value of oaiJ was observed in Li+ 
saturated GTP solutions containing 1.5 mM Mg2+, suggesting competition of these two cations 
for phosphate groups in GTP (Figure 9C). Similar observations were found in GDP solutions; 
however, the chemical shift changes of the two phosphate resonances were not as large as for 
GTP at the same concentrations because of the lower affinity of Li+ and Mg2+ to GDP. 
Using the 31P NMR chemical shifts for the phosphate resonances of GTP and GDP, 
three different models (see III.3A.) were applied to generate binding constants. For GTP in 
the presence of LiCl alone, the E2 values in Table 5 suggest that the best nonlinear least-
squares fit to the 31P NMR data was the model based on a mixture of 1: 1 (LiGTP) and 2: 1 
(Li2GTP) species (third model). The theoretical chemical values (othe0 ,) for this model, as well 
as those for the first model based on 1: 1 species, however, are unrealistic and showed no 
convergence in some cases. The binding constants for the 2: 1 species were larger than those 
for the 1: 1 species for both the Li-GTP and Li-GDP complexes, irrespective of the fitting 
model used. Based on both E2 and otheor values, the overall best fits for the stoichiometry of 
Li+ complexes of GTP or GDP are those in which Li2GTP and Li2GDP species predominate 
with binding constants, respectively, of 550 ± 200 M-2 and 60 ± 15 M-2• The 2: 1 species 
also predominated in aqueous solutions of ATP or ADP in the presence of Li+ alone (23). 
The calculated binding constants were higher for Li2GTP than for Li2GDP because of the 
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higher charge of GTP than of GDP. 
The fit of the 31P chemical shift data for the Mg-GTP and Mg-GDP complexes (Table 
5) yielded otheor values which were consistent with the observed data. The binding constants 
obtained, 2xl04 M-1 and lxl04 M- 1, agree with those reported previously for GTP and GDP 
(131,132). The fit of the 31P chemical data for the Mg2+ titration of GTP or GDP was 
insensitive, however, to the absolute values of the binding constants as manifested by large 
E2 values (Table 5). 
The 31P chemical shifts for u+ /Mg2+ mixtures of GTP or GDP were interpreted based 
on the three models for the predominant species in solution; the binding constants and the 
theoretical limiting chemical shifts are summarized in Table 6. For GTP, the third model 
which assumed the presence of both LiGTP and Li2GTP species in Li+ /Mg
2+ mixtures yielded 
the best E2 values and reasonable otheor values. The binding constants for the 1: 1 species, 
however, were very small, indicating that the Li2GTP species predominates in Li+ /Mg
2+ 
mixtures, having an overall binding constant of 1060 ± 350 M-2• The overall binding 
constant of Li+ to GTP is not significantly different in the absence (550 ± 200 M-2) or in the 
presence of Mg2+ (1060 ± 350 M"2). For GDP in Li+/Mg2+ mixtures, no convergence was 
found when only the presence of LiGDP species in solution was assumed (first model). While 
good convergence was found for the /j-phosphate resonance of GDP when we used the second 
model (Li2GDP species only), better convergence was found for both the ex- and /j-phosphate 
resonances with the third model (mixture of LiGDP and Li2GDP). The third model, however, 
yielded unrealistically high Li+ binding constants for GDP and poor agreement between 
observed and theoretical limiting 31P chemical shifts. The most reliable Li+ binding constant 
for GDP in the presence of Mg2+ is that of the /j-phosphate resonance of the Li2GDP species 
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with the second model, 645 M-2 , which is higher than that calculated from 31P data measured 
in the absence of Mg2+ (60 ± 15 M 2). The large error involved in the calculation of the 
binding constants indicates, however, that this difference may not be significant. The increase 
in the calculated Li2GDP binding constant in the presence of Mg
2
+ suggests that simultaneous 
binding of u+ and Mg2+ to the two phosphate groups of GDP may be present. The 7Li T1 
values in Li+ /Mg2+ mixtures in the presence of GDP (Figure 6) are consistent with 
competition between u+ and Mg2+ for the same binding sites in GDP. Thus, the common 
u+ and Mg2+ binding sites in GDP are not the sugar and base domains (Table 6), but 
presumably the a- and ,B-phosphate groups of GDP. 
31P NMR measurements of cAMP and AMP showed no changes in chemical shifts upon 
metal ion addition, except for the sample of AMP containing a high concentration of Mg2+ 
(50 mM) where a small upfield shift was found. The stability constant of AMP to Mg2+ is 
known to be very weak (93 M-1) (133) compared to those of ATP (1.15 x 105 M-1) and GTP 
(1.05 x 104 M-1); therefore only small changes are observed in the 31P NMR spectrum of AMP 
at high Mg2+ concentration. The upfield shift was due to the interaction between Mg2+ and 
AMP which changed the torsion angle of the phosphate group of AMP; an increase in bond 
angle results in an upfield chemical shift (134). The charge of cAMP is lower than that of 
AMP at the same pH; Li+ and Mg2+ binding to cAMP should be weaker than to AMP and 
can ont be observed by 31P NMR spectroscopy (Table 9). Though u+ and Mg2+ interact 
weakly with cAMP, it is still possible for competition between Mg2+ and Li+ to exert an 
effect on the activity of adenylate cyclase via metal ion competition to the phosphate groups 
of ATP. 
Similar 7Li spin-lattice relaxation measurements were obtained for IP3 as for GTP and 
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GDP, indicating competition between Li+ and Mg2+ for binding sites in IP 3 (Figure 11). No 
changes were observed in the 'H NMR spectra of IP3 in the presence of excess amounts of 
u+ or Mg2+ (Figure 12A; Table 12), suggesting that the phosphate groups are the only 
potential binding sites for metal ions in IP 3• 
Upfield shifts in the 31P phosphate resonances, predominantly with the 4- and 5-
phosphates of IP 3 were found upon addition of Li+ or Mg2+, suggesting interaction of Li+ and 
Mg2+ to the 4- and 5-phosphate groups of IP3 • This observation is consistent with the 
previous study in 50 mM-Tris/100 mM-KCI, and at pH 7 .1 ( 135). The metal ion interactions 
probably affected the conformation of IP 3, which caused the change in p-orbital symmetry and 
in the 0-P-O torsion angle (134). No study on conformational changes was reported for 
Ins(l,4,5)P3 upon addition of Li+ or Mg2 \ but a similar conformational change was observed 
in sodium phytate by addition of Li+ (136). 
The binding constant of Mg2+ to Ins(l,4,5)P3 was measured by 'H NMR to be 281 M- 1 
at pH 6.9 and low ionic strength; and it decreased with the ionic strength (135). Though 
the u+ binding constants to Ins(l,4,5)P3 have not been reported, they have already been 
studied by potentiometry in solutions of Ins(l ,2,6)P3 at 25 °C in 0.1 M But4NBr; they were 
240 M-1 and 4000 M-2 at l: 1 and 2: 1 ratio, respectively (137). However, the binding constant 
for Mg2+ to Ins(l,2,6)P3 was 4.0 x 105 M- 1 under similar conditions (138). It seems that 
the affinity of Mg2+ changed drastic from Ins(l,2,6)P3 to Ins(l,4,5)P3 ; this may not be real 
but due to the different experimental conditions and methods used. Nonetheless, based on 
the information currently available, we conclude that the interaction of Li+ and Mg2+ to 
phosphate groups in Ins(l ,4,5)P3 is not negligible. 
By using NMR spectroscopy, we found that ATP, GTP, GDP and IP3 are the potential 
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target sites for Li+ in second messenger systems. As a result, we conclude that Li+ may 
achieve its pharmacological effect on G proteins, adenylate cyclase and phosphoinositide 
turnover by competing with Mg2+ for phosphate-binding sites, in ATP, GTP, GDP and IP3• 
The mechanism of Li+ action on second messenger systems is not clear. It could exert 
its effect via G proteins, by competition with Mg2+ binding sites, and regulate adenylate 
cyclase and phosphatidyl inositol turnover. However, it is also possible for Li+ to exert its 
effect directly on adenylate cyclase by the same mechanism via competition with Mg2+ binding 
sites in ATP. The phosphatidyl inositol tum over system is complex with many potential sites 
for u+ interaction. The inhibition of Mg2+ on Ins(l,4,5) binding to its receptor was also 
found in human uterine membranes ( 139) and in dog cerebellum (140), suggesting Mg2+ may 
exert an important regulatory control on the release of Ca2+ by Ins(l,4,5)P3• The proposed 
mechanism involves direct chelation of Mg2 + by Ins(l ,4,5)P3 or by its receptor. White et al. 
(135) suggested the latter postulation based on the low affinity of Mg2+ for Ins(l ,4,5)P3 which 
they observed at physiological ionic strength. It has been reported that u+ inhibited the 
Mg2+ -dependent inositol monophosphatase enzyme (22). The effect of Li+ is not simply 
restricted to inositol monophosphatase; it can also inhibit other enzymes involved in 
phosphatidyl inositol turnover such as InsP2 , InsP3 and InsP4 phosphatase (141). It is therefore 
still questionable whether Li+ exerts its effect directly on Ins(l ,4,5)P3 or indirectly by 
changing its accumulation rate. Nevertheless, u+ could compete with Mg2+ for binding to 
Ins(l ,4,5)P3 • Metal ion competition could potentially lead to a change in the interaction 
between IP3 and its receptor resulting in different amounts of released Ca2 +. 
We used u+ concentrations that were approximately ten times higher than those present 
in the intracellular compartments of bipolar patients receiving lithium carbonate. The 
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sensitivity of the NMR methods used in this investigation would not enable us to observe 
appreciable changes at lower concentrations of Li+. With more sensitive methods of Mg2+ 
analysis, such as fluorescence, it may be possible to determine whether a u+ /Mg2+ 
competition mechanism for phosphate-binding sites in GTP bound to a purified G protein or 
other substrates of the second messenger systems operates at therapeutic u+ concentrations. 
Most ligands that bind Li+, including ATP, will also bind Mg2+ and Ca2+ with even 
higher affinity (142). When ligands with high Mg2+ affinity (e.g., the RBC membrane) are 
also present, the absolute values of the stoichiometric binding constants do not necessarily 
reflect the tendency of Li+ to bind preferentially to ATP. Based on the calculations of 
conditional binding constants, it was found that the organic ligands uramildiacetate and 
o-carboxyphenyliminodiacetate, which have a set of three oxygens and one nitrogen 
coordination sites, can compete for one-fourth or one-half of the Mgz+ bound to 3.2 mM ATP 
(142). The intracellular u+ and Mg2+ concentrations are of the same order of magnitude in 
tissues of manic-depressive patients undergoing lithium therapy; the Ca2+ concentrations are 
however four to five orders of magnitude smaller than those of Li+ implying that Ca2+ dose 
not appreciably compete with Li+ for binding to biological ligands. The intracellular Na+ and 
K+ concentrations are approximately two orders of magnitude larger than those of Li+; any 
ligand with conditional binding constants which are two log units smaller for Na+ and K+ than 
for Li+ will preferentially bind Li+. Most ligands meet this criterion, and therefore 
competition between Li+ and Mgz+ can conceivably take place in the presence of 
physiologically relevant intracellular Na+ and K+ concentrations (142). 
Based on 7Li T 1 data, the calculated stoichiometric binding constants of Mg
2+ and u+ 
to the RBC membrane were approximately 3.3 x 103 M- 1 (KMg-~ and 1. 7 x 1()2 M- 1 (Ku-M). 
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Based on 31P chemical shift data (23), the binding constant for the species MgATP was 
calculated to be approximately 2.0 x 104 M- 1 (KMgATP), whereas from 7Li T 1 data, the overall 
binding constants for the species LiA TP and Li2A TP were approximately 8. 7 x 10
2 M- 1 
(KLiATP), and 1.1 x 104 M-2 (f3ue-TP), respectively. 
In the presence of ATP, the conditional binding constants for Mg2+ (K' Ms-M) and u+ 
(K'u-M) binding to the RBC membrane were derived (Section III.3C.). The conditional 
binding constants are dependent on free concentrations of ATP ([A TP]r) and Li+ ([Li +lr). 
Figure 22 shows the calculated conditional binding constants, obtained from equation (21) and 
(22), as a function of free ATP concentration (in the range 10-4 M to 1 M). Equation 22 
requires an estimate of the free Li+ concentration; to obtain an approximate concentration of 
free u+, we assumed that most Li+ was bound to ATP in the form of Li2ATP. For a typical 
total intracellular Li+ concentration of 1.0 mM, the free u+ concentrations are of the order 
of 10-4 M; therefore, the term 2[ATPlr[Li+]J3LizATP in equation 22 does not significantly affect 
the estimation of K'u-M· For [ATP]r values larger than 1.0 mM (Fig. 22), Li+ will bind 
as strongly as Mg2+ to the RBC membrane. Typical free intracellular ATP concentrations 
in RBCs are of the order of 0.2 mM. From Figure 22, we estimate, for typical free 
intracellular ATP concentrations (-log[ A TP]r = 3. 69), that the ratio of the conditional binding 
constants of Mg2+ over Li+ to the RBC membrane is approximately 4. In contrast, in the 
absence of ATP the ratio of the stoichiometric binding constants of Mg2+ over Li+ to the RBC 
membrane is approximately 20. These calculations indicate that, for typical intracellular 
[ATP]r values, Li+ can compete with approximately 25% of Mg2+ binding sites in the RBC 
membrane. As the total intracellular Li+ concentration increases in RBCs, the free 
concentration of ATP decreases and the ratio of conditional binding constants increases. 
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Figure 22. Logarithmic Plot of Mg2+ (dots) and u+ (crosses) Conditional Binding Constants 
to the RBC Membrane against Free ATP Concentration. 
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Thus, in the presence of both ATP and RBC membrane, u+ can compete with some of the 
Mg2+ bound to ATP and to the RBC membrane. Competition between Mg2+ and Li+ for ATP 
coupled with binding of the displaced Mg2+ to the RBC membrane of Li+ -loaded RBCs is 
therefore energetically favorable. 
V.2. Transmembrane Difference on 7Li NMR T1 Values, and on the Rate of Li+ Uptake 
in Human RBCs 
RBCs contain hemoglobin (Hb) which is a mixture of oxy and deoxy forms. Whereas 
the form of Hb present in deoxyRBC is paramagnetic, that present in CORBC is diamagnetic 
(98,99). Two types of RBCs were prepared to examine the paramagnetic effect on 
intracellular 7Li T1 values. Despite the different magnetic environments of intracellular Li+ 
in deoxyRBC and CORBC samples, the intracellular 7Li T1 values observed in the two cell 
suspensions are in good agreement (6. 7 ± 0.1 s vs. 5.9 ± 0.1 s, n=2); thus, a 
transmembrane difference in 7Li T 1 values can be observed in human RBC suspensions 
irrespective of the state of cell oxygenation. 
Komoroski and coworkers (109) found that, for a Li+ concentration of 50 mM at a high 
hematocrit (85%) and at 37 °C, the extracellular 7Li+ T1 value was 8.2 ± 0.8 s, whereas the 
intracellular 7Li+ T 1 value was 6.5 ± 1.0 s. In contrast, our intracellular 7Li+ T 1 value at 
85% hematocrit and at 37 °C was consistent with theirs, but our extracellular T1 value was 
at least twice as great, though the extracellular 7Li + T 1 value at 84 % hematocrit was 
significantly lower (p < 0.05) than the values obtained at hematocrits of 11, 33, 45 and 67%. 
The lower extracellular 7Lt T 1 value at 84% hematocrit may be associated with the rise in 
sample viscosity at this hematocrit. The hematocrit-independent intracellular 7Li + T 1 values 
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are controlled mostly by Li+ binding to the RBC membrane, and not by intracellular viscosity 
(92,122). 
It is difficult to establish the source for this discrepancy because the procedures for the 
sample preparations used in the previous relaxation studies were not explicitly stated (109). 
The observed 7Li+ T 1 values in RBC suspensions are a weighted average of the T1 values for 
free and bound u+ ions; the observed values are dependent on the u+ concentration in each 
cell compartment. We do not know whether the u+ concentrations shown in their Table 1 
(109) refer to the concentration of the Li+ -loading medium or represent the actual intra- and 
extracellular u+ concentrations. Alternatively they may represent the average u+ 
concentration over the entire RBC suspension. The possibility that their reported Li+ 
concentrations represent the actual concentrations of Li+ in the two cell compartments is 
unlikely because the highest intracellular Li+ RBC concentrations that can be obtained after 
12 h of incubation are typically in the range of 10 to 15 mM (95,143), as opposed to the 50 
mM concentration stated in their Table 1 (109). 
The total accumulation time for their T1 measurements was not specified (109). Within 
1 h of incubation, an appreciable amount of Li+ influx and efflux will occur, particularly with 
RBCs suspended in a Na+-containing medium (27,95,143). The "NMR buffer" which was 
used in the previous study (109) contained a high concentration of Na+, whereas in our 
relaxation experiments we minimized the amount of Na+-u+ exchange by using a choline-
medium. In our study, the extracellular 7Li+ T1 values for fresh Li+ -free RBCs suspended at 
85% hematocrit in an isotonic medium containing 50 mM LiCl, 62 mM choline chloride, 10 
mM glucose, 85 mM sucrose, and 10 mM HEPES, pH 7.4, after 15 and 75 min, respectively, 
were 14.8 ± 0.5 sand 13.5 ± 0.9 s (n = 2); the intracellular u+ concentration after 75 min 
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as determined by AA was 1.7 mM. However, the extracellular 7Li+ T1 value for fresh Lt-
free RBCs suspended at 85 % hematocrit in an isotonic medium containing 5 mM LiCl, 105 
mM choline chloride, 10 mM glucose, 85 mM sucrose, and 10 mM HEPES, pH 7.4, after 
75 min was 10.5 ± 1.5 s (n = 2); the intracellular Lt concentration determined by AA was 
0.3 mM. Thus, we were also able to observe shorter T1 values in RBC suspensions incubated 
for at least 1 h with u+ at low extracellular concentrations; however, the T1 values measured 
under these conditions are not due to extracellular Li+ alone, but to a mixture of intra- and 
extracellular u+ ions. 
Whether the ideal osmolarity of the incubation medium was maintained at 300 mosM 
in the previous study ( 109) is not clear. If the Li+ concentrations reported in their Table 1 
(109) refer to the average u+ concentration over the entire RBC suspension, their cell 
suspensions would be far from being isotonic. A solution of 50 mM LiCl has an ideal 
osmolarity of 100 mosM; if no other salts are added, it will constitute a hypotonic medium 
for RBCs which can induce cell lysis. We also observed T1 values in the range of 8.0 to 13.0 
s for u+ -free RBCs incubated in a hypotonic medium containing 50 mM LiCl alone; an 
appreciable amount of cell lysis was present, however, in these RBC suspensions, as indicated 
by the high concentrations of hemoglobin (approximately 2.0 mM) present in the supernatant. 
The partial lysis of RBC suspensions, which occurs upon incubation in a hypotonic medium, 
affords decreased extracellular 7Li T 1 values because the observed values represent a mixture 
of intra- and extracellular Li+ ions, and because hemoglobin, which is known to bind Lt 
weakly, is present in the suspension ( 119, 144). 
Possible reasons for the inability of Komoroski et al. (109) to observe a transmembrane 
difference in T 1 values in human RBC suspensions (109) may be related to uncontrolled 
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osmolarity of the incubation medium and consequently to cell lysis, Na+ /Li+ exchange induced 
by the presence of Na+ in the suspension medium, and/or Li+ redistribution across the RBC 
membrane during the course of a long relaxation measurement. The precautions have 
described in detail (82,86) to be taken during 7Li MIR measurements of u+ transport in 
human RBC suspensions. Although the relaxation behavior of the spin 3/2 7Li nucleus is 
complex (77,109,122), it should be possible to explore both 7Li T 1 and 7Li T2 values to obtain 
novel information concerning the biological action of Li+ in manic-depressive patients 
(27,92,145). 
Using nuclear magnetic resonance methods, we found, for a given starting u+ 
concentration in the extracellular medium, that the initial rate of Li+ influx into fresh human 
red blood cells (RBCs) from an isotonic medium decreased with increasing hematocrit (Table 
14A and Figure 15). 
In previous 7Li NMR transport experiments, Komoroski et al. (109) varied the 
hematocrit, initial extracellular Li+ concentration, and temperature simultaneously (Fig. 1 of 
ref. 109). The initial rate of u+ uptake in RBC suspensions is expected to increase with 
increasing initial extracellular Li+ concentration. With increases in both the hematocrit to 
85% and in the starting extracellular Li+ concentration to 50 mM, the percentage of 
intracellular Li+ that they observed at 85 % hematocrit was lower than that at 45 % hematocrit 
and at a lower initial extracellular Li+ concentration, 1.8 mM (Table 14B) (109). If they had 
monitored the initial Li+ influx in terms of intracellular Li+ concentrations, and not in 
percentages of intracellular Li+ relative to the total amount of Li+ present over the entire RBC 
suspension, they would also have found that the initial rate of Li+ uptake increases with 
simultaneous increases in hematocrit and starting extracellular Li+ concentration (Table 14B), 
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as predicted above. Although two different temperatures (25 °C and 37 °C) were used in their 
experiments (109), it is unlikely that this temperature difference significantly affected the 
pharmacokinetics of Li+. 
In separate procedures (Fig. 2 of ref. 109), Komoroski et al. observed that the 
percentage of intracellular Li+ measured after 12 h of incubation in an RBC suspension having 
an average Li+ concentration of 3.5 mM over the entire sample increased with increasing 
hematocrit; based on this observation, they concluded that the rate of Li+ uptake into RBCs 
increased with increasing hematocrit. Because the amount of Li+ added to the suspension 
medium was constant, the starting extracellular Li+ concentration increased (from 3.7 mM to 
11.7 mM) with increasing hematocrit (from 5% to 70%). Moreover, the percentage of 
intracellular Li+ at a higher hematocrit may appear to be larger than that at a lower hematocrit 
because of the larger number of cells in the NMR window, and not because of an increase 
in intracellular Li+ concentration with increasing hematocrit. If they had also monitored Li+ 
influx in their second set of experiments in terms of intracellular Li+ concentrations, they 
would again have found that the limiting intracellular Li+ concentration decreases with 
increasing hematocrit after 12 h of incubation (Table 14C). The equilibrium concentration 
gradient also increases with increasing hematocrit (Table 14C), as under our experimental 
conditions. The "NMR buffer" used by Komoroski et al. (109) contained a high concentration 
of Na+ (140 mM). Under these conditions, a significant amount of u+ efflux via the Na+ -
Li+ exchange pathway (intracellular Li+ exchanging with extracellular Na+) occurs after 12 
h of incubation. The extent of Li+ efflux via the Na+ -Li+ exchange pathway also depends on 
hematocrit (27,95,143). In our experiments (Fig. 15), we minimized the contribution ofNa+-
u+ exchange by using an incubation medium that contained the K+, and not the Na+, form 
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of the shift reagent, and by monitoring Li+ influx every hour over a shorter incubation time 
(8 h vs. 12 h); the residual amount of Na+ in the shift reagent (8.0 mM Na+ concentration 
in the suspension) is unlikely to cause significant u+ efflux via the Na+-u+ exchange 
pathway. Although the K+ medium used in our studies is less relevant physiologically than 
is the Na+ medium used in the previous study (109), no direct conclusions can be drawn 
concerning Li+ influx into RBCs suspended in a Na+ medium because of the existence of the 
Na+-u+ exchange pathway (27,95,143). Thus, in their second set of experiments (Fig. 2 of 
ref. 109), Komoroski et al. (109) also varied two parameters simultaneously, both the starting 
extracellular u+ concentration and the hematocrit, and did not allow for u+ efflux via the 
Na+ -Li+ exchange pathway. This led to a misleading conclusion concerning the effect of 
hematocrit on Li+ uptake in RBC suspensions. 
A comparison of the Li+ transport results obtained from our experiments, in which only 
one experimental parameter was changed (Table 14A), with Komoroski's results in which 
three parameters (Table 14B) or two parameters (Table 14C) were changed simultaneously, 
could lead to misleading conclusions regarding the effect of hematocrit on Li+ uptake in RBC 
suspensions. We clarified in the present study the effect of hematocrit on the 
pharmacokinetics of u+ through the definition of various u+ uptake transport parameters, 
namely, initial rate of Li+ influx, limiting values of both intracellular Li+ concentration 
([Li+]°" in) and Li+ percentage (%Li+"' in), and equilibrium concentration gradient. Table 14 
shows that, in all experiments, the equilibrium concentration gradient increased with increasing 
hematocrit. The decrease in [Ln"' in values with increasing hematocrit obtained in our 
experiments (Table 14A) was in agreement with Komoroski's second set of experiments (Table 
14C), but there were discrepancies with their first set of data (Table 14B) regarding the effect 
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of hematocrit on the initial rate of u+ uptake, and on [Li+]"" in and %Li+"" in values. These 
discrepancies result from the large increase in the starting extracellular Li+ concentration, 
which limits the loading capacity of RBCs with u+ as manifested by the decreased %Li+"" in 
values at high hematocrit (Table 14B). Regarding the initial rates of u+ influx, one would 
anticipate that, for a fixed starting extracellular Li+ concentration and at a lower hematocrit, 
extracellular u+ can more rapidly populate the membrane transport sites, leading to a higher 
initial rate of u+ influx, which we indeed observed (Table 14A). At high starting 
extracellular u+ concentrations, the membrane transport sites may be saturated with u+ at 
all hematocrits, leading to an increase in initial rates of Li+ influx with increasing hematocrit 
(Table 14B). 
In conclusion, depending upon the way in which the Li+ concentration is defined in the 
blood sample, it may appear that changes in hematocrit have opposite effects on the rate of 
u+ uptake in cell suspensions. Because bipolar patients receiving a given dose of lithium 
carbonate have the same starting extracellular Li+ concentration, and not necessarily the same 
starting u+ concentration over the whole cell suspension (cells plus plasma), the uptake of 
Li+ in cells from patients with reduced cytocrit values is expected to be faster initially than 
that in cells from patients with normal cytocrit values. Patients with reduced cytocrit values 
would also have an increased limiting intracellular u+ concentration. In patients with reduced 
cytocrit values, such as anemic patients or human immune deficiency virus-infected individuals 
on zidovudine therapy (146), toxicity could develop when lithium therapy is initiated. 
However, because u+ itself also induces the production of granulocytes (147), patients 
receiving long-term lithium therapy will most likely have normal rates of u+ uptake. 
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V.3. Identification of Li+ Binding Sites in Erythrocytes 
Slow motions contribute only to T 2 whereas fast motions such as those components of 
motions at the resonance frequency contribute to both T 1 and T 2 ( 116). The observation of 
a large difference between 7Li + T 1 and T 2 values in Li+ -loaded RBCs (Table 15) is indicative 
of a long correlation time for intracellular Li+. When Li+ ions are subject to substantial 
electric field gradients or are immobilized in the membrane, the 7Li T/T2 ratio increases; the 
larger the ratio, the stronger the interaction. We therefore used 7Li T/T2 ratio measurements 
to determine the internal and external Li+ binding sites in RBC suspensions. 
Based on the known RBC composition, one can predict what the Li+ binding sites might 
be. Glycophorins account for 90% of the total sialic acid residues and thus the outer cell 
surface has a negative charge (148). In principle, these residues can interact or bind the 
positively charged Li+ ion. No difference was found between the 7Li T1 and T2 values of 
the extracellular u+ resonance for RBC suspensions treated and untreated with sialidase (93); 
the presumably weak interaction between Li+ ions and sialic acid residues does not account 
for the large T /T 2 ratio observed in Li+ -loaded RBCs. It is possible that not all the sialic acid 
residues were released by treatment with sialidase. However, if specific sialic acid - Li+ 
interactions were present, one would expect an increase in 7Li relaxation times after treatment 
with sialidase, which was not observed. The relaxation data do not support the presence of 
specific sialic acid - u+ interactions. 
RBCs are often thought of as packets of Hb. Intracellular Li+ may also be interacting 
with hemoglobin. In the present study, u+ was also found to bind weakly to Hb (Table 16). 
Our Hb data are in agreement with published results (122, 123) which indicate weak Li+ -Hb 
interactions. We also found that the paramagnetic properties of deoxyHb or metHb which 
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might be present in partially oxygenated u+ -loaded RBCs is not responsible for the large 
value of the T/T2 ratio. The small value of the T/T2 ratio obtained for u+ -containing 
glycerol/water mixtures indicates that the high intracellular viscosity, which is associated with 
large concentrations of Hb in RBCs, is not responsible for the large difference between 7Li 
T1 and T2 values. 
Pettegrew and coworkers (122) measured the 7Li T1 and T2 relaxation values for RBCs 
incubated with 50 mM u+ (concentration expressed over total volume of cells and suspension 
medium) and found them to be approximately 5.1 and 0.15 s, respectively. They speculated 
that the large difference in relaxation times was due to diffusion of Li+ ions across the 
heterogeneous electrostatic field gradients generated by the SA network of the RBC 
membrane. However, no direct investigation of Li+ diffusion through the SA network or of 
u+-SA binding was conducted by Pettegrew et al. (122); their speculation was based on 
measurements obtained with agar gels. In this study, we investigated directly the contributions 
of Li+ diffusion through the SA network and of Li+ -spectrin interactions by measuring 7Li T 1 
and T2 values in spectrin solutions containing LiCl (1.5 - 5.0 mM) - see Table 16. From the 
small R values observed in u+ -containing spectrin solutions, we conclude that diffusion of 
the Li+ ion through the SA network is not responsible for the large T /T2 ratio present in Li+ -
loaded RBCs. From the small dependence of the observed 7Li relaxation values on the 
spectrin concentration and the small R values, we conclude that only weak Li+ interactions 
with SA are present for Li+ levels typically present in RBCs. Ca2+, and to a smaller extent 
Mg2+, bind strongly to erythrocyte spectrin (149); it is therefore unlikely that therapeutic 
concentrations of Li+ would compete with physiological intracellular concentrations of Ca2+ 
and Mgz+. The small values of the T /T 2 ratios observed with Li+ solutions containing 
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physiologic concentrations of DPG and ATP (Table 17) also indicate weak u+ -DPG and u+ _ 
ATP interactions, which is agreement with the literature (23,133). 
The large T/T2 ratios observed with unsealed RBC membrane suspensions (Table 19) 
indicate that the large difference between T 1 and T2 values observed in u+ -loaded RBCs is 
due to specific interactions between Li+ and membrane binding sites. Because stronger Li+ 
binding was observed for extravesicular u+ in the presence of IOV than in ROV (Figure 17), 
we conclude that the inner leaflet of the RBC membrane provides the major Li+ binding sites 
in Li+ -loaded RBCs. The lipids of the erythrocyte membrane are asymmetrically distributed 
(40). The outer leaflet of mature human RBC contains approximately 40-50% PC, 40-50% 
sphingomyelin (SM) and 10-15 % phosphatidylethanolamine (PE) of the total outer leaflet 
phospholipids, whereas the inner leaflet contains approximately 10-20% PC, 10% SM, 40-
50% PE, 20-30% PS and 1.4% PI of the total inner leaflet phospholipids (40,150,151). Both 
anionic phospholipids, PS and PI, are found only in the inner leaflet. The intrinsic binding 
constants for interactions between some alkali and alkaline earth metal ions and PS have been 
reported (152); they are 0.8 M- 1 for PS - Na+, 4.0 M-1 for PS -Mg2+, and 35 M-1 for PS -
Ca2+. Evidence for Li+ interactions with PS-containing liposomes was previously obtained 
from 7Li relaxation data (153,154). Therefore, it is likely that the anionic phospholipids PS 
and PI present in the inner leaflet of the RBC membrane contribute toward u+ binding 
(Figure 17). The SA network is also present in the inner leaflet of the RBC membrane. For 
similar protein concentrations, however, the R value for spectrin solutions containing 1.5 mM 
u+ was 4.4 whereas that of RBC membrane suspensions was 49 (Table 19). We therefore 
conclude that the SA network is not responsible for the enhanced Li+ binding present in IOV 
suspensions (Figure 17). 
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Apparent affinity binding constants for Na+ and u+ ions to the internal and external 
binding sites of the RBC Na+ -Li+ exchange (countertransport) membrane protein were 
previously determined from Lineweaver-Burk plots (155, 156); on both membrane surfaces, 
a 15 to 18 fold preference of u+ over Na+ was found. Interestingly, the absolute values for 
the binding affinities for Li+ and Na+ were 3 fold greater for the internal than for the external 
binding sites. The difference in ion affinities on the two RBC membrane surfaces may be due 
to excess internal negative charge associated with the presence of anionic phospholipids, PS 
and PI, in the inner RBC membrane surface. Previous studies (26, 157) on the lipid 
composition of RBC membranes from bipolar and hypertensive patients have shown that the 
amounts of PS and PI are different from those present in RBCs from normotensive 
individuals. 
Li+ binding to RBC anionic phospholipids may be affecting the extent of lipid-protein 
interactions in the RBC membrane. Since the Na+-Na+ exchange protein, which mediates 
RBC Na+-u+ countertransport, is a membrane protein, it is feasible that different extents of 
u+ binding to phospholipids, and in turn different extents of interactions between anionic 
phospholipids and the membrane-bound Na+ -Na+ exchange protein, could be responsible for 
the variations in RBC u+ countertransport reported for bipolar (10,11,27) and hypertensive 
(95 ,96) patients relative to normotensive individuals. Although the Na+ -Na+ exchange protein 
is known to bind Li+ with high affinity (155, 156), its low abundance in the RBC membrane 
makes it unlikely that Li+ binding to the Na+ -Na+ exchange protein is solely responsible for 
the drastically short intracellular 7Li T2 values observed in u+ -loaded RBC suspensions. The 
contribution of the Na+ -Na+ exchange toward the observed 7Li T /T 2 ratio in Li+ -loaded RBCs 
cannot be determined directly at the present time because the RBC Na+ -Na+ exchange 
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membrane protein has not been isolated yet, and highly specific transport inhibitors are not 
available. 
V .4. 7Li Relaxation Behavior in RBC Membrane Suspensions 
The 7Li nucleus has a nuclear spin, I, of 3/2, and is therefore a quadrupolar nucleus. 
The quadrupole moment of 7Li is however small (75). Nuclear Overhauser enhancement 
measurements and H20-D20 exchange experiments showed that dipolar coupling to 
1H 
contribute approximately 20% toward the relaxation of intracellular Li+ in RBC suspensions 
(109, 122). Contributions from spin rotation, chemical shift anisotropy, and scalar relaxation 
mechanisms have also been ruled out (109). Our observations of similar T/T2 ratios for 
RBCs bubbled with either N2 or CO, and of small T/T2 ratios for both paramagnetic 
(deoxyHb and metHb) and diamagnetic (COHb) forms of Hb (Table 16) indicate that 
paramagnetic relaxation is not an important relaxation mechanism for intracellular Li+ in 
. 
RBCs. Despite its small quadrupole moment, the major mechanism for relaxation of the 7Li 
nucleus in Li+ -loaded RBCs is therefore quadrupolar relaxation. 
Under the extreme narrowing condition (w2r2 < < 1, where w is the NMR observation 
frequency, and r is the correlation time), the T 1 value should be similar to the T 2 value (75). 
Because the intracellular 7Li T 1 values are significantly larger than the T2 values in Li+ -loaded 
RBCs (Table 15), the extreme narrowing condition does not apply to the relaxation of 
intracellular Li+. Outside the domain of motional extreme narrowing, and assuming that the 
relaxation and exchange times in the bound state are much shorter than those in the free state, 
the quadrupolar relaxation decay for a nucleus with I = 3/2 is biexponential (158). In 
similarity to the two-state model for spin 3/2 nuclides undergoing chemical exchange, a model 
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that assumes asymmetric continuous distribution of correlation times for the fluctuating electric 
field gradients experienced by the spin 3/2 nuclides in biological samples also predicts 
biexponential relaxation (77). A Lorentzian line shape, which is observed in the extreme 
narrowing condition, is characterized by a tl11 11/tl111,2 ratio of 2.7 (80). Outside the domain 
of motional extreme narrowing, however, a non-Lorentzian line shape is observed which can 
be deconvoluted into a narrow Lorentzian curve, originating from the slow T 2s relaxation 
component and accounting for 40% of the total signal intensity, and a broad Lorentzian curve, 
owing to the fast T2f relaxation component and accounting for the remaining 60% of the total 
signal intensity; similarly, the observed T 1 values under this condition can be decomposed into 
slow Tis components that contribute 80%, and fast T1r components that account for the 
remaining 20% of the observed T, relaxation. The narrow or slow component of T, or T2 
relaxation is associated with the -1/2 to + 1/2 transition, whereas the broad or fast component 
is due to the -3/2 to -1/2 and the + 1/2 to +3/2 transitions (80). 
Our partially relaxed 7Li NMR spectra of RBC membrane suspensions containing 20 
mM LiCl (Figure 18) provided evidence for biexponential relaxation for the 7Li nucleus. 
When the mole fraction of free Li+ was very large relative to that of bound Li+, as it was the 
case in RBC membrane suspensions containing 150 mM LiCl or in a glycerol/water mixture 
with the same Li+ concentration, we were, however, unable to detect biexponential decay for 
the T 1 relaxation. The T 1 values observed in Li+ -containing RBC membrane suspensions 
represent weighted averages of free Li+ in exchange with Li+ bound to RBC membrane sites. 
Because the relaxation of Li+ in the absence RBC membrane is monoexponential, the 
environment the Lt experienced is homogeneous. The relaxation behavior of 150 mM LiCl 
in the presence of RBC membrane appears to be monoexponential because of the large 
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fraction of free Li+. The T 1 r and T 1s values for 20 mM Li+ in the presence of RBC 
membrane were 9.0 s and 11.5 s yielding a ratio of less than two for spin-lattice relaxation 
rates. Low sensitivity may preclude the separation of fast and slow relaxation components 
when they differ by a factor of less than two (158). Komoroski et al. (109) did not observe 
biexponential T 1 or T2 relaxation, or a double-quantum 
7Li NMR resonance for u+-loaded 
RBCs; the inability to detect biexponential relaxation for the 7Li nucleus in Li+ -loaded RBCs 
may be associated with a low signal to noise ratio for the intracellular 7Li NMR resonance 
(158). We observed full visibility for the 7Li nucleus in Li+ -containing RBC membrane 
suspensions (this study) and in Li+ -loaded RBCs (27). The observation of partial visibility 
of the intracellular 7Li NMR resonance and the inability to detect biexponential relaxation 
(109) may be associated with low NMR sensitivity under the experimental conditions 
previously used. Precedents for biexponential relaxation and partial visibility of the 23Na 
nucleus in human RBC and rat liver have been reported (109,159,160). Apparent 
monoexponential 23Na relaxation and a large difference between T 1 and T2 was also reported 
for intrac~llular Na+ in human packed RBCs (161). 
Changes in Li+ binding sites, in particular anionic phospholipids, may be responsible 
for the abnormal Li+ transport properties in RBCs from bipolar and hypertensive patients. 
Changes in the phospholipid composition (162) or activities of enzymes involved in 
phospholipid metabolism and interconversion (163) require investigation; such studies may 
contribute to an understanding of the etiology of bipolar illness, other neurological diseases 
as well as essential hypertension. Our 7Li NMR relaxation results indicate the promise of 
relaxation measurements to probe Li+ interactions in disease states. 
147 
V.5. Relationship Among Li+ /Na+ Countertransport Rate, Phospholipid Composition, 
and Li+ Binding to Human RBC Membrane from Bipolar Patients Receiving 
Lithium Carbonate 
In this study, as in most reports (35,95,124-127) the rates of RBC Na+-Li+ exchange 
were measured as the efflux of Li+ from u+-loaded RBCs in exchange with Na+ present in 
the suspension medium. Under the standard assay conditions, Li+ is present at saturating 
concentrations, but Na+ is not (37,38,164), the dissociation constants (KM) for extracellular 
Na+ are of the same order of magnitude as extracellular Na+ concentration, 140 mM, used 
in the standard assay indicating that the RBC Na+ -Li+ exchange protein is far from saturated 
with Na+ on the extracellular side of the RBC membrane. The rates that we obtained in this 
study, as well as the rates that have been reported by others (35,95,124-127) under the 
standard assay conditions are therefore not maximal velocities of RBC Na+-Li+ exchange; 
variations in Na+ affinity (KM) and maximal velocity (V maJ could change the observed rates 
in RBCs of lithium-treated patients. By monitoring bipolar patients for the first week after 
initiating lithium treatment, Ehrlich et al. (35) observed by using AA an increase in the KM 
values and yet no change in the V max values. In contrast, inter-individual differences observed 
in the rates of Na+ -Li+ exchange in RBCs of lithium-treated patients were attributed to 
changes in the v max values but not in the KM values (29,35,165). These previous findings on 
the effect of lithium treatment on the kinetic properties of RBC Na+ -Li+ exchange need, 
however, to be reevaluated in light of the now known transport Na+ unsaturation under 
standard assay conditions (37,38,164). 
When 7Li relaxation measurements are used for probing variations in Li+ binding to the 
RBC membrane, unsealed RBC membrane samples are preferable to intact Li+ -loaded RBCs 
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because the Li+ concentration can be adjusted more precisely and the extent of Li+ binding 
to the RBC membrane is enhanced. With intact Li+ -loaded RBCs, the intracellular Li+ 
concentration may change during the course of a long 7Li NMR relaxation measurement as 
a result of Na+-u+ countertransport. The extent of Li+ binding in intact u+-loaded RBCs 
is less than that in unsealed RBC membrane samples because of weak binding of intracellular 
Li+ to anionic intracellular components such as hemoglobin, 2,3-diphosphoglycerate, and 
adenosine triphosphate. 
The Li+ binding constants that we calculated from the 7Li T 1 values measured in Li+ -
containing suspensions of unsealed RBC membranes are measures of Li+ binding to the 
phosphate head groups of phospholipids and protein binding sites present in the internal and 
external surfaces of the RBC membrane. In contrast, the KM values obtained by varying the 
intra- or extracellular Li+ concentrations in the standard assay (29,35,165) are measures of 
u+ binding to intra- or extracellular sides of the membrane exchange protein. Not 
surprisingly, the Li+ binding constants (which are the reciprocals of KM values) reported for 
the transport measurements (which are in the range of 500 M-1 to 3800 M-1) (35,155,156) are 
significantly different from the Kb values of Li+ that we measured by using 7Li NMR 
spectroscopy (Tables 24 and 25). Interestingly, the l/KM values of Li+ for inner surface of 
the RBC membrane obtained under Li+ efflux conditions was three-fold greater than KM values 
for the outer surface (155,156); the larger negative surface charge, associated with a large 
percentage of the anionic phospholipids PS and Pl, of the inner leaflet of the RBC membrane 
may also contribute toward the KM values measured by the standard transport assay. Na+ -
u+ exchange activity occurs only when Li+ and Na+ gradients are present across the RBC 
membrane (166). The values of Kb are smaller than those of l/KM presumably because the 
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7Li NMR binding measurements were conducted on unsealed RBC membrane suspensions 
which contain an inactivated exchange protein, whereas the KM values were obtained from 
transport experiments conducted on intact RBC suspensions. 
The phospholipid composition of the human RBC membrane that we observed by 31P 
NMR is in general agreement with that observed by Sengupta et al. (26), who used thin - layer 
chromatography. However, 31P NMR yielded higher percentages of PC, Sph, and PS, and 
lower percentages of PI and PE, than those measured by thin-layer chromatography. The 
different percentage compositions measured by the two methods is attributed to the fact that 
31P NMR measures the total phosphate in each phospholipid; the visualization reagent used in 
thin-layer chromatography (iodine vapor or cupric acetate) results in detection of only 
unsaturated fatty acids by chromatographic methods (127,167). 
Previous observations have suggested that alterations in plasma lipids and RBC 
membrane lipid composition may be associated with the decreased rates of RBC Na+-u+ 
exchange reported for lithium-treated psychiatric patients and the elevated rates of Na+ -Li+ 
exchange in RBCs of hypertensive patients (168-171). An alteration in plasma lipid 
composition, triggered by genetic or other unknown exogenous or endogeneous factors, could 
result in alterations in phospholipid membrane composition via exchange between plasma and 
membrane lipids. Alterations in lipid-protein interactions in cell membranes could result in 
variations in the rates of Na+ -Li+ exchange (170). Changing the amount of cholesterol in the 
RBC membrane or replacing the native PC by derivatives of PC containing fatty acids with 
various degrees of saturation resulted in significant changes in the rates of RBC Na+-u+ 
exchange (172). However, dietary supplementation with olive oil caused significant changes 
in plasma lipids and RBC membrane fatty acids, and yet the rates of RBC Na+-u+ exchange 
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were maintained (173). Therefore, in previous measurements on the total amount of fatty 
acids in the RBC membrane it was not possible to identify the subclasses of phospholipids that 
regulate the activity of the RBC Na+-u+ exchange protein. By using 31P NMR spectroscopy, 
however, we were able to measure alterations in the percentage membrane composition of the 
anionic phospholipids PI and PS in lithium-treated bipolar patients. 
Because PS is a phospholipid with a head group bearing a negative charge, the 
interaction of PS with Li+ is expected to be strong. Evidence for binding of Li+ to the 
negatively charged head group of PS comes from studies on synthetic membranes by 7Li, 
31P, and 2H NMR and by neutron diffraction (153,154,174). We found that the percentage 
of PS in RBC membrane of lithium-treated patients was significantly stronger binding of u+ 
to the head groups of PS located in the inner leaflet of RBC membrane, and in slower rates 
of RBC Na+ -Li+ exchange. Because u+ causes inhibition of myo-inositol-1-phosphatase 
(91), lithium treatment is associated with decreased levels of myo-inositol and decreased 
biosynthesis of PI in the brain (175, 176). Moscovich et al. (177) have also shown decreased 
activity of inositol-1-phosphatase in RBCs of lithium-treated bipolar patients. The non-
significant decrease in PI content that we observed by 31P NMR spectroscopy in RBC 
membranes of lithium-treated patients agrees with previous observations. Because of baseline 
noise and small amounts of PI present in RBC membranes, it is only possible to determine 
the PI content with an accuracy of ± 20%; the low accuracy of the PI content measured by 
31P NMR spectroscopy may explain our failure in observing a significant difference in PI 
levels between the patients and control groups. 
Our NMR measurements of phospholipid composition and Li+ binding to the RBC 
membrane provided a clear discrimination between lithium-treated bipolar patients and normal 
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individuals. To rule out a drug-induced effect, we are currently investigating whether a 
similar discrimination exists between lithium-free bipolar patients and normal individuals in 
RBC phospholipid composition and u+ binding constants. Measuring the affinity of Na+ for 
the RBC membrane proved to be a promising tool to identify patients who are at risk of 
developing essential hypertension (38). By using 31P NMR spectroscopy, Pettegrew et al. 
(178) obtained evidence for abnormal membrane phospholipid metabolism in the brains of 
schizophrenic patients. An investigation at the molecular level of the factors responsible for 
the abnormal rates of Na+ -Li+ exchange in RBCs of bipolar patients may lead to the 
identification of the abnormalities in the RBC Na+ -Li+ exchange protein. More precisely 
defined molecular parameters, such as phospholipid composition and Lt binding constants, 
may be useful for the diagnosis and prognosis of bipolar patients as well as for predicting the 
usefulness of lithium treatment. 
In summary, we found that an alteration in the anionic phospholipid composition of the 
RBC membrane of manic-depressive patients receiving lithium carbonate resulted in stronger 
u+ binding to the RBC membrane and lower rates of Na+ -Li+ exchange. Opposite trends 
were observed for normal individuals. We are now investigating Li+ binding to RBC 
membranes from bipolar patients who are Li+ -free to establish whether abnormal Li+ binding 
to RBC membranes is related to the etiology of manic depression (12,179) or is a result of 
u+ therapy (34,35). 
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